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Summary 
 
Pharmacokinetic interactions often occur as a result of changes in the functional expression of 
drug-metabolising and transporting proteins. In recent years, interactions of herbal medicines 
with synthetic drugs have come into focus and drug-interactions for more than 150 herbal 
medicines have been reported including the most prominent hypericum. Importantly, also 
dietary drug-food interactions have been observed, grapefruit juice presenting the most 
famous herein.  
Systemic elimination and uptake of xenobiotics is regulated, predominantly in the liver but also 
in other extrahepatic tissues including the gut, by their biotransformation and excretion. In the 
metabolic conversion of drugs the cytochrome p450 (CYP) enzyme family is the major catalyst 
of phase I drug biotransformation reactions. The isoenzymes most commonly involved in drug 
metabolism include CYP3A4, which is also the most abundantly expressed CYP, and 
CYP1A2. The absorption, distribution, and excretion of endogenous and ingested substances 
is mediated by membrane transporter proteins. In this context, the transporters P-glycoprotein 
(P-gp) and multidrug-resistance associated protein 2 (MRP2), both located in the apical 
membrane of enterocytes, exert a key role in the gastrointestinal tract. The interplay of 
CYP3A4 and P-gp in limiting oral drug availability is emphasised by their striking overlaps of 
substrates and inhibitors. Overexpression of particular drug transporters can even lead to the 
phenotype of drug resistance, which is often observed in cancer patients. However, therapy 
resistance has also been observed in other diseases such as inflammatory bowel disease 
(IBD). 
 
Green tea (Camellia sinensis (L.) O. KUNTZE, fam. Theaceae) is one of the most popular 
beverages in the world and has been reported to exert beneficial effects on several life-style 
related diseases. These have been ascribed to several potential activities of green tea or 
single constituents thereof, such as antiinflammatory and anticancer activities. However, a 
potential modulation of drug metabolism by green tea described in the literature remains 
controversial. 
 
The aim of the thesis was to investigate in vitro the influence of a commercially available green 
tea extract (GTE) on the gastrointestinal drug metabolism and transport. These results might 
be of therapeutical relevance and/or useful in the prediction of the outcome of future clinical 
trials. Therefore, the effect of GTE on the expression of different CYPs and membrane 
transport proteins was assessed in two established intestinal cell lines, LS-180 and Caco-2 
cells. Additionally, the influence of GTE on metabolic or transport activity was also investigated 
in vitro. 
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 Green tea has been reported to modulate the generation of reactive oxygen species (ROS) 
under cell culture conditions. This effect may lead to the generation of artefacts, especially in 
mRNA induction experiments. In view of this, preliminary experiments excluded an influence of 
GTE on hydrogen peroxide concentrations in the medium (Chapter 2). 
 
The effect of GTE, or constituents thereof, on the mRNA expression of the two efflux pumps P-
gp and MRP2 was investigated in LS-180 cells (Chapter 3). mRNA expression levels were 
determined by quantitative RT-PCR. Due to their location in the apical membrane of 
enterocytes, these transporters exert the first obstacle in the uptake of orally ingested 
xenobiotics. At low concentrations GTE was found not to modulate the mRNA expression of P-
gp or MRP2. Functional assays using a cell line stably overexpressing human MRP2 (MDCK-
MRP2) showed an inhibition of the extrusion of methotrexate, a MRP2 substrate, by GTE at 
high concentrations (Chapter 3). In concentrations corresponding to their content in GTE, none 
of the green tea constituents tested did exert this inhibitory activity on MRP2 function. 
In two intestinal cell lines, Caco-2 and LS-180, the effect of GTE on CYP1A1 and CYP1A2 
mRNA expression was assessed using quantitative RT-PCR (Chapter 4). CYP1A2 mRNA 
expression was inducible by GTE in a dose-dependent manner in both cell lines. GTE 
influenced CYP1A1 expression differentially in these cell lines. mRNA expression of CYP1A1 
was only induced in the Caco-2 cell line. These data were confirmed on the protein level by 
western blot experiments. No effect of GTE on CYP3A4 mRNA expression levels was 
observed in LS-180 cells. However, GTE showed a dose-dependent inhibition of CYP1A2 and 
CYP3A4 metabolic activity in vitro using luminescent substrates. 
These data demonstrate that dietary substances might have an impact on therapeutic 
effectiveness by a possible influence on drug uptake and metabolism. Additionally, the 
chemopreventive character implicated for GTE might be explained by an inhibition of the 
generation of carcinogenic intermediates by CYP1A2. 
 
The gut mucosa represents a site of active immunological activity potentially involved in the 
initiation of an immune response to inflammatory stimuli. Intestinal epithelial cells are capable 
to secrete proinflammatory mediators like chemokines and cytokines in response to such 
stimulants. Chemokines are involved in the regulation of leukocyte migration from the blood 
into the inflamed tissue and play an important role in the generation of the respiratory burst in 
these cells. A prominent member of the chemokines is interleukin (IL)-8, which acts on 
neutrophils. An increased expression of this chemokine has been observed in enterocytes in 
inflammatory bowel diseases and in several gastrointestinal cancers. 
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Antiinflammatory and chemopreventive activities have been described for green tea in the 
literature. Therefore, in this thesis we wanted to clarify the effect of GTE on the potential of 
enterocytes to produce proinflammatory mediators. Due to inconclusive results concerning 
different cytokines or enzymes involved in arachidonic acid metabolism (Chapter 6.3), the 
focus was laid on IL-8 expression and secretion in Caco-2 cells (Chapter 6.1). Induction of IL-8 
mRNA expression by GTE at highest dose was shown by quantitative RT-PCR. While this lead 
to an increase of intracellular IL-8 protein concentration, the excretion of IL-8 was specifically 
inhibited by GTE as demonstrated by EIA (Enzyme-linked immunosorbent assay) detection. 
GTE dose-dependently inhibited the induction of IL-8 secretion by the proinflammatory 
stimulus IL-1β. However, these results give evidence for an anti-inflammatory activity of GTE 
in enterocytes, which might result in a decreased infiltration of neutrophils in the inflamed 
tissue. Thus, GTE might be useful for acute treatment of intestinal inflammation. 
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Aim of the thesis 
 
The major goal of the thesis was to reveal possible influences of a commercially available 
green tea extract (GTE), namely EFLA®942, on intestinal drug absorption and metabolism. 
The focus was laid on membrane transporters and phase I metabolising enzymes involved in 
intestinal first-pass clearance of the majority of xenobiotics. By providing in vitro data from 
intestinal cell lines we might be able to predict possible drug-drug interactions with GTE. 
Additionally, these results offer an estimation on the influence of GTE co-ingestion on oral 
bioavailability of drugs and on therapy resistance. However, it has to be emphasised that 
further in vivo studies are needed to clarify the effects of GTE on intestinal drug absorption and 
metabolism in humans. 
 
 
Therefore, we intended to generate data concerning the influence of GTE on the following 
aspects in intestinal cell lines: 
 
• mRNA expression levels of the ABC transporters P-gp and MRP-2 
• Functional activity of the ABC transporter MRP-2 
• Expression of CYP1A and CYP3A4 with regard to mRNA or protein levels 
• Functional activity of CYP1A2 and CYP3A4 
• Intestinal epithelial barrier function 
 
 
Additionally, in vitro data were generated concerning the anti-inflammatory activity of GTE on 
proinflammatory mediators. The focus was set on chemokines and cytokines involved in 
chronic intestinal inflammation including inflammatory bowel disease (IBD). The effect of GTE 
on the following topics was investigated using an intestinal cell line model: 
 
• IL-8, IL-1β, and TNF-α mRNA expression levels 
• IL-8 mRNA decay 
• IL-8 protein secretion 
• IL-8 protein expression levels 
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1. Introduction 
 
1.1 Drug absorption and metabolism in the gastrointestinal tract 
Along the mammalian digestive tract, which represents the internal barrier between the 
environment and the organism, the gastrointestinal mucosa serves as a highly selective barrier 
designed to permit the absorption of nutrients from the gut lumen into the circulation and to 
restrict the passage of potentially toxic xenobiotics (Farhadi et al., 2003). Two major routes 
exist for the permeation of this barrier, namely transcellular and paracellular transport, which 
require the respective cellular systems. Paracellular transport is mainly controlled by tight 
junctions (Hollander, 1992). Additionally, the cytoskeleton plays an important role in 
paracellular transport, beside its critical function together with adherens junctions in the 
maintenance of the intestinal barrier function (Alvila, 1987). For transcellular transport 
membrane transport proteins play a pivotal role (Baumgart and Dignass, 2002). 
The small intestine principally serves as the site for absorption of nutrients, water, and 
xenobiotics. Accordingly, it has become apparent that enterocytes lining the intestinal mucosa 
are equipped with a broad range of metabolic systems such as phase I and II drug 
metabolising enzymes associated with different efflux pumps (Kaminsky and Fasco, 1992; 
Suzuki and Sugiyama, 2000). Morphologic features of the small intestine increase its 
metabolic competence as well as its potential for first-pass metabolism. These include the 
remarkable length of 7 m in humans divided into the duodenum, jejunum, and ileum 
(proximally to distally), the appearance of the metabolic competent epithelium as an enterocyte 
monolayer, as well as further amplification of the epithelial surface by villi and crypts 
(Kaminsky and Zhang, 2003). However, the small intestine determines the bioavailability of the 
majority of orally ingested drugs, beside their physiochemical properties, by metabolism and 
active extrusion after absorption (Suzuki and Sugiyama, 2000). The importance of the 
isoenzyme cytochrome P450 (CYP) 3A4, the major phase I drug metabolising enzyme in 
humans, and P-glycoprotein (P-gp), the multidrug efflux pump, in limiting oral drug delivery has 
been suggested due to broad overlapping substrate specifities and poor oral bioavailability of 
joint substrates of both proteins (Wacher et al., 1996). Additionally, many compounds induce 
or inhibit both proteins simultaneously (Schuetz et al., 1996). Phase II drug-metabolising 
enzymes are able to conjugate xenobiotics with small organic donors, e.g. glutathione, by 
taking advantage of electrophilic functional groups already present on the molecule, or ones 
introduced by CYPs (McCarver and Hines, 2001). In most cases these conjugations result in 
detoxification and pharmacological inactivation and may render the xenobiotics to substrates 
for specific transport enzymes like the multidrug-resistance associated proteins (MRPs), thus 
facilitating excretion to the lumen. 
 15
The steroid and xenobiotic receptor (SXR), or pregnane X receptor (PXR), an orphan nuclear 
receptor with high abundance in liver and intestine, has been shown to exert a central role in 
the expression of P-gp and CYP3A4 and other ABC transporters and CYP isoforms (Lehmann 
et al., 1998; Synold et al., 2001). After activation by a diverse array of substances including 
rifampicin and hyperforin, PXR forms heterodimers with retinoic X receptor, another nuclear 
receptor, and then specifically interacts with a DNA sequence, the hormone-binding element. 
As many of the compounds that induce CYP3A4 and/or P-gp activate or bind directly to PXR, 
this receptor could be exploited for a screening of drug candidates, which fail to activate or 
inhibit this pathway (Lehmann et al., 1998; Geick et al., 2001). In addition, the constitutive 
androstane receptor (CAR) with high expression in the liver and intestine plays an important 
role in the expression of ABC transporters (Kullak-Ublick and Becker, 2003). Moreover, 
expression of P-gp may be induced by stress signals including heat shock, genotoxic stress, or 
cytokines, as respective transcription binding sites have been located in the MDR1 promotor 
region (Sukhai and Piquette-Miller, 2000). In the CYP1A enzyme family, each member is 
inducible via the aryl hydrocarbon receptor (AhR). Ligand binding to AhR induces 
conformational changes, which enables AhR to translocate to the nucleus, where it dimerizes 
with the AhR nuclear translocator protein (ARNT). These heterodimers function as 
transcriptional activators by binding to consensus sequences called dioxin-response elements 
(DRE) (Denison and Whitlock, 1995). 
The general importance of drug metabolising enzymes and transport proteins is given by their 
control of metabolism, absorption, distribution, and excretion of endogenous substances and 
exogenous xenobiotics in the organism. The high abundance of these metabolising enzymes 
and transport proteins in the liver and in the small intestine has raised the question about the 
contribution of each of these organs to the first-pass metabolism of xenobiotics. The greater 
metabolic capacity due to a higher overall weight relative to the small intestine and a higher 
concentration of CYPs and of microsomal protein content, as well as the potential of absorbed 
systemic xenobiotics to undergo countercurrent exchange, would favour the liver (Lin et al., 
1999). Nevertheless, this does not detract from the capability of the small intestine, as the first 
site of exposure, to metabolise or extrude orally ingested xenobiotics prior to systemic uptake. 
Thus, it is worthwhile to assess possible interactions of drugs of dietary origin, e.g. green tea, 
in view of a possible therapeutic potential and/or possible drug-drug interactions leading to 
reduced therapeutical effectiveness. 
 
 
1.2 ABC transport proteins 
The ATP-dependent efflux pumps belong to a family of ATP-binding cassette (ABC) 
transporters that share sequence and structural homology, which compromises the 
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characteristic ATP-binding cassette, consisting of two nucleotide-binding domains. So far, 
about 50 human ABC genes have been identified and divided into seven distinct subfamilies 
(ABCA-ABCG) on the basis of their sequence homology and domain organization (Dean et al., 
2001). ABC transporters are widely distributed in different tissues, which highlights their 
importance in the transport of numerous endogenous substances in addition to exogenously 
administered drugs (Gottesman et al., 2002). ABC transporters are transmembrane proteins 
located in the plasma membrane where they can mediate anti-gradient transport of an array of 
distinct substances in an ATP-dependent fashion. In this thesis focus has been laid on ABC-
transporters located in the apical membrane of polarized intestinal mucosal cells. 
The first ABC-transporter identified as drug-resistance protein was P-gp (ABCB1, MDR1) 
(Juliano and Ling, 1976), while other ABC family members were discovered later (MRPs, 
ABCC). Remarkably, a second MDR gene (MDR2) is expressed in humans, that is specific for 
phosphatidylcholine translocation in cells. Overexpressed in tumour cells, P-gp causes the 
multidrug resistant (MDR) phenotype by active extrusion of a wide range of cancer 
chemotherapeutic drugs (Patel and Rothenberg, 1994). Due to the fact that not all tumour cells 
with this phenotype express P-gp, other ABC-transporters were identified to confer multidrug-
resistance including many MRP family members as well as the recently discovered breast 
cancer resistance protein (BCRP, ABCG2). The latter transporter is thought to be a 
homodimer of two half-transporters, each containing an ATP-binding domain (Komatani et al., 
2001; Gottesman et al., 2002). 
 
1.2.1 MDR1 (ABCB1) 
P-glycoprotein (P-gp), a glycoprotein of about 170 kDa, consists of 12 transmembrane 
domains and two nucleotide-binding sites and functions as an energy-dependent drug efflux 
pump that lowers intracellular drug concentrations. Beside its occurrence in cancer cells, P-gp 
is expressed at high levels on the apical surfaces of epithelial cells of tissues such as the liver 
(bile canaliculi), kidney (proximal tubule), pancreas (pancreatic ductile cell), small intestine and 
colon (Thiebaut et al., 1987). Besides, P-gp is also expressed in the capillary endothelium of 
the brain and testes (Schinkel et al., 1994). In these tissues P-gp mediates the efflux of 
xenobiotics and toxins into the intestinal lumen, urine, bile, and blood. Along the intestine, 
alterations of P-gp mRNA expression levels from duodenum to sigmoid colon were reported 
with the highest expression in the terminal ileum (Zimmermann et al., 2005). A strong 
interindividual expression of P-gp protein was observed in small intestinal biopsies (Lown et 
al., 1997b). Additionally to the extrusion of orally administered dugs, hence forming a first line 
of defence, P-gp secretes intravenously administered drugs into the gastrointestinal tract 
(Sparreboom et al., 1997). 
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P-gp has a broad substrate specificity covering a large variety of structurally diverse 
substances (Wacher et al., 1995). In general, these substrates are hydrophobic, and/or 
organic cations. Drug-drug interactions occur when a substance modulates cellular P-gp 
activity, which results in an altered efflux of other substrates. These may origin from a change 
of P-gp expression, direct inhibition of P-gp function, and/or agonist properties of the 
substance. Several substances have been reported to increase plasma levels of a P-gp 
substrate, digoxin, due to an inhibition of P-gp-mediated efflux, e.g. verapamil and ritonavir 
(Verschraagen et al., 1999; Ding et al., 2004). P-gp modulators such as cyclosporin A and 
verapamil were able to interrupt the transport of anti-cancer agents, which are substrates of P-
gp, e.g. irinotecan (Ma and McLeod, 2003). 
 
1.2.2 MRP2 (ABCC2) 
Multidrug-resistance associated protein 2 (MRP2) is a member of the MRP family of 
membrane proteins, which so far comprises nine members (MRP1-9). All of the MRPs 
possess the characteristic ATP-binding cassette motive but they vary in the number of their 
transmembrane domains. The MRP family members that have been functionally characterized 
so far share the property of transporting anionic conjugates and amphiphatic organic anions. 
Many of these transport proteins enable the sequestration and terminal excretion of conjugates 
formed in phase II metabolism (Keppler, 1999). 
MRP2 (ABCC2, cMOAT) is localized in the canalicular membrane of hepatocytes, in the apical 
membrane of proximal tubules in the kidney, and in the apical surface of intestinal epithelial 
cells (Gottesman et al., 2002; Keppler, 1999). In these tissues MRP2 mediates the export of 
metabolites into bile, intestinal lumen, and urine. Noteworthy, the MRP1 (ABCC1) isoform 
shares about 50% sequence homology with MRP2 and is expressed in all tissues. MRP1 and 
MRP3 (ABCC3), which has a similar tissue distribution as MRP2, are located on the 
basolateral membrane of intestinal mucosal cells, where they extrude substrates into the 
interstitium and the bloodstream. MRP1, MRP2, and MRP3 act as conjugate export pumps 
and exhibit overlapping substrate specificities, but with significant kinetic differences (König et 
al., 1999). The localization of MRP2 in the apical membrane of polarized epithelial cells 
favours a particular role in detoxification by the terminal excretion of conjugation products such 
as glutathione S-conjugates, glucuronides, and sulfoconjugates. Together with MRP1, MRP2 
exports oxidized glutathione and therefore contributes to the GSSG/GSH ratio as well as to the 
antioxidative defence potential of the cell (Leier et al., 1996). In chemotherapy, MRP2 has the 
potential to confer resistance to chemotherapeutical agents including vincristine, doxorubicine, 
cisplatin, and methotrexate (Cui et al., 1999; Ma and McLeod, 2003; Hooijberg et al., 1999).  
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1.3 Cytochrome P450 (CYP) enzymes 
The CYP superfamily is the major enzyme family responsible for the oxidative 
biotransformation of a variety of endogenous substrates such as steroids, prostaglandins, bile 
acids, and xenobiotics including drugs and carcinogens (Wrighton et al., 1996). CYPs are 
localized in the smooth endoplasmatic reticulum of numerous tissues. They are heme-
containing monooxygenases, which mediate oxidation reactions, where an incorporation of an 
oxygen atom from O2 into the target molecule takes place, while the remaining oxygen atom is 
reduced to water. First the substrate binds to the heme iron, where a transfer of an electron of 
NADPH happens. After the attachment of oxygen and an uptake of a second electron the 
ternary complex dissociates and CYP, hydroxylated substrate, and water are set free. The 
substrate specificity of CYP is determined by the ability of a potential substrate to bind in the 
active site of the enzyme, by the ability to promote electron transfer to the heme iron, and by 
the extent of which completion of the catalytic cycle occurs without uncoupling of NADPH and 
oxygen utilization from substrate oxidation (De Voss et al., 1997). 
The CYP superfamily is the predominant player in xenobiotic phase I metabolism. Among the 
three CYP gene families involved for most drug metabolism in humans, namely CYP1, CYP2, 
and CYP3. Among the different CYP isoenzymes, CYP1A1, CYP1A2, and CYP3A4 are 
involved in the biotransformation of a wide array of xenobiotic compounds (Nelson et al., 
1996). CYP3A is the principal subfamily responsible for CYP-mediated phase I metabolism of 
more than 50% of administered drugs (Zhang and Benet, 2001). Studies on intestinal CYP 
expression revealed CYP3A as the predominant subfamily in enterocytes (Watkins et al., 
1987; Kolars et al., 1992) and in the liver (Shimada et al., 1994), comprising about 30% and 
70%, respectively.  CYP1A, which is one of the most abundant CYPs in the liver, participates 
in the metabolic activation of polycyclic aryl hydrocarbons (PAH) to mutagenic and 
carcinogenic derivatives, which are often highly reactive but unstable intermediates 
(Guengerich and Turvy, 1991). Beside the first-pass clearance, CYP-mediated drug 
metabolism can lead to altered bioavailability of therapeutic agents or tissue burdens of foreign 
compounds. Additionally, it can lead to altered drug efficacies through inactivation of an active 
drug or activation of a prodrug. As most drugs have extrahepatic target tissues, the extent and 
characteristics of target tissue drug metabolism may influence the effectiveness of treatment. 
Moreover, toxic compounds may be detoxified after CYP-mediated biotransformation, and inert 
xenobiotics may be activated to become toxic compounds. Therefore, genetic polymorphisms 
in CYP activity or effects of substrates including dietary compounds on this activity might 
influence therapeutic effectiveness and/or toxic burden of tissues. Thus, these substrates 
might alter susceptibility to disease induced by toxins or reactive intermediates, such as 
smoking-induced cancer (Whitlock, 1999). 
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1.3.1 CYP1A 
The CYP1A subfamily consists of two members, CYP1A1 and CYP1A2. The CYP1A enzymes 
are responsible for the metabolism of many chemical carcinogens found in the environment 
and diet. CYP1A mediated metabolism of these carcinogens creates highly reactive 
intermediates that possess mutagenic and carcinogenic activity (Gonzalez and Gelboin, 1994). 
CYP1A1 metabolises important polycyclic aromatic hydrocarbon carcinogens such as 
benzo[a]pyrene and benz[a]anthracene, while CYP1A2 is a primary pathway for the 
metabolism of caffeine and also metabolises carcinogens as arylamines and aflatoxins. The 
expression of CYP1A1 in the small intestine seems rather to be inducible than constitutive, 
while CYP1A2 has not been detected in small intestinal biopsies (Ding and Kaminsky, 2003). 
Also data from biopsy tissues on CYP1A expression in the colon remains inconclusive 
(Mercurio et al., 1995; McKinnon et al., 1993). However, CYP1A was inducible in colon 
carcinoma cell lines (Ding and Kaminsky, 2003). 
 
1.3.2 CYP3A 
Studies on small intestinal and colonic CYP expression revealed CYP3A as the predominant 
subfamily in enterocytes (Watkins et al., 1987; Peters and Kremers, 1989; Ding and Kaminsky, 
2003). CYP3A protein and catalytic activity decrease longitudinal along the small intestine 
(Wacher et al., 1998). The importance of the small intestine in determining oral drug 
bioavailability has been demonstrated with the CYP3A4 substrate midazolam (Paine et al., 
1996). Modulation of intestinal midazolam metabolism has been demonstrated with different 
CYP3A4 inhibitors such as saquinavir or grapefruit juice (Palkama et al., 1999; Lown et al., 
1997a). A high interindividual variability of CYP3A4 has been described (Wacher et al., 1998). 
 
 
1.4 The gastrointestinal tract as a site of immunological activity 
The mucosal surfaces of the gut, covered by a barrier of epithelial cells, are protected by 
epithelial secretion products such as mucins, defensins, and secretory antibodies as well as by 
epithelial specializations including tight junctions and apical surface coats. Despite their 
protective function, mucosal tissues are sites of intense immunological activity. Epithelial cells 
continuously provide the mucosal immune system with information about the external 
environment by transporting foreign antigens across the epithelial barrier. This transport 
occurs along the gastrointestinal tract and is concentrated at sites that contain organized 
mucosa-associated lymphoid tissues (MALTs) (Neutra et al., 2001). Single lymphoid follicles 
and follicle-associated epithelium (FAE) increase in frequency in the distal ileum, where they 
are organized in large patches (Peyer’s patches), and colon, where the microbial flora is 
abundant and diverse. In humans the greatest frequency of FAE occurs in the rectum and in 
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dead-ended extensions of the intestinal lumen such as the cecum and appendix (O’Leary and 
Sweeney, 1986). In contrast to the villus epithelium, which is dominated by absorptive 
enterocytes, mucin-secreting goblet cells and enteroendocrine cells, the FAE predominantly 
consists of specialized M cells. These mediate transepithelial vesicular transport of foreign 
material directly to intraepithelial lymphoid cells and to MALTs and are therefore crucial for the 
induction of protective mucosal immune responses (Neutra et al., 1996). Consequently, due to 
their mucosal entry port function, M cells are involved in the pathogenesis of certain bacterial 
and viral diseases. In comparison to the villus epithelium, FAE exerts a lower expression of 
digestive membrane-associated hydrolases, as well as a reduced mucus, defensin, and 
lysozyme production, and IgA secretion into the intestinal lumen (Neutra et al., 2001). These 
features promote local contact of intact antigens and pathogens to the FAE. However, 
intestinal epithelial cells (IEC) are considered to generally participate in the initiation and 
regulation of a mucosal immune response. Accordingly, activated IEC secrete a variety of 
inflammatory mediators such as chemokines, e.g. interleukin (IL)-8 and Groα, and cytokines 
such as IL-1β and IL-6 (Yang et al., 1997; Woywodt et al., 1994). Corresponding mucosal 
inflammatory states have been observed in several gastrointestinal diseases including 
inflammatory bowel disease (IBD) and colorectal cancer (Sartor, 1994; Csiszar et al., 2004). 
A continuous migration of activated lymphocytes, macrophages, and granulocytes from the 
circulation into the mucosa is a hallmark of chronic inflammation of the intestine. Further 
upregulation and exacerbation of destructive processes is the result of this constant influx of 
leukocytes, which is caused by a wide variety of different proinflammatory and chemoattractant 
molecules (MacDermott, 1999). These are released by phagocytes and a variety of cells like 
IEC in the inflamed tissue upon activation with inflammatory stimuli. The composition of 
leukocytes present in the inflamed intestine is probably determined by secreted chemokines as 
well as by the expression of the respective receptors on different cell types. Secreted 
chemokines establish a chemotactic gradient within the intestine, which directs the migration of 
leukocytes from the blood through the endothelium into the mucosa and submucosa. The 
characteristic tissue damage found in IBD, Crohn’s disease and ulcerative colitis, result from 
matrix metalloproteinases from granules, whose exocytosis is induced by chemokines. 
Additionally, chemokines are able to activate the respiratory burst, which potentially 
contributes to these lesions. Thus, selective chemokine inhibitors, which could diminish the 
severity of the inflammatory response, are of great interest as potential therapeutic strategies 
in IBD. 
 
1.4.1 Chemokines 
Chemokines (chemotactic interleukins) constitute a superfamily of small (8-10 kDa), inducible, 
secreted, proinflammatory cytokines, which comprises about 40 known members. They 
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primarily act as chemoattractants and activators of specific types of leukocytes. Three classes 
of chemokines have been defined by the arrangement of the conserved cysteine (C) residues 
in the mature protein: the CXC chemokines that have one amino acid separating the first two 
conserved cysteins, e.g. IL-8, Groα, ENA-78; the CC chemokines in which the first two 
conserved cysteine residues are adjacent, e.g. RANTES, MIP-1α; the C chemokines which 
lack two of the four conserved cysteine residues, e.g. lymphotactin. A chemokine-like structure 
with three amino acids between the first two cysteins (CX3C) at the N-terminal end of a mucin 
structure has also been described (Baggiolini, 1998). They differ in their biological activity on 
leukocytes populations depending on the pattern of expression of their receptors. Many 
chemokines bind to more than one receptor, and most receptors recognize more than one 
ligand of the corresponding subfamily. This demonstrates a characteristic redundancy and 
versatility of the chemokine system. 
Five receptors for CXC chemokines (CXCR) and eight receptors for CC chemokines (CCR) 
have been characterized (Murphy, 1996). These receptors are coupled to GTP-binding 
proteins. Chemokine binding to leukocytes induces a shape change, based on actin 
remodelling, which leads to the formation and retraction of lamellipodia. Adherence of 
leukocytes to endothelial cells of the vessel wall before migration into the tissue is mediated by 
an upregulation and activation of integrins upon chemokine stimulation (Springer, 1994). Other 
rapid and transient responses are characteristic of leukocyte activation by chemokines 
including the rise of intracellular free calcium concentration, the production of oxygen radicals 
and bioactive lipids, and the release of the contents of cytoplasmic storage granules like 
proteases from neutrophils and monocytes, histamine from basophils and cytotoxic proteins 
from eosinophils (Baggiolini et al., 1997). 
 
1.4.2 IL-8 
The CXC chemokine family member IL-8, a protein of about 8 kDa, was identified 1987 as a 
novel type of neutrophil-activating cytokine (Baggiolini et al., 1989). Besides in IEC, its 
expression and secretion was observed in endothelial cells and fibroblasts of different tissues, 
keratinocytes, synovial cells, chondrocytes and even neutrophils. IL-8 is generated as a 
precursor of 99 amino acids and is secreted after cleavage of a signal sequence of 20 
residues. Several biological active variants are generated by extracellular N-terminal cleavage, 
with a predominant variant of 72 amino acids. It is a basic protein and contains four cysteins, 
which form two disulfide bridges required for its biological activity (Baggiolini and Lewis, 1992). 
IL-8 activates with high affinity two receptors, CXCR-1 and CXCR-2, which are constitutively 
expressed in neutrophils. Both receptors are subject to homologous and heterologous 
desensitisation leading to a progressive attenuation of cellular response after prolonged 
exposure of neutrophils to IL-8 (Ali et al., 1999). Homologous desensitisation by IL-8 involves 
 22
internalisation of agonist-occupied receptors, degradation of IL-8 by lysosomal enzymes, and 
reexpression of the receptor on the cell membrane (Samanta et al., 1990). Beside a 
mechanism for limiting cellular response, receptor internalisation, in combination with 
reexpression, appears to be a fundamental step for chemotaxis. Due to differences in the IL-8 
concentration dependence of receptor internalisation, the two receptors seem to induce 
different chemotactic behaviour. In contrast to CXCR-1, CXCR-2 desensitisation and 
internalisation are faster and occur at lower concentrations of IL-8. Therefore, CXCR-2 
function might be dominant at sites distant from the inflammation, while CXCR-1 plays a more 
important role in the centre of an inflammation (Chuntharapai and Kim, 1995). Coherently, the 
respiratory burst, which is solely mediated by CXCR-1, appears predominantly in the centre of 
inflammation, where it is most efficiently. CXCR-2 is too rapidly desensitised and internalised 
to mediate phospholipase D activation and superoxide anion production, which are needed to 
generate the respiratory burst (Zeilhofer and Schorr, 2000). 
In colonic biopsies of IBD patients, IL-8 expression was shown to be upregulated and IL-1β 
and TNF-α have been proposed as pivotal mediators of the mucosal chemokine response 
(Puleston et al., 2005). Furthermore, increased IL-8 expression was observed in human 
colorectal carcinoma cells and an increase of IL-8 expression was associated with an 
enhanced metastatic potential in colon carcinoma cells (Csiszar et al., 2004; Li et al., 2001). 
Therefore, IL-8 seems to represent an important player in several diseases. 
 
 
1.5 Green tea (Camellia sinensis (L.) O. KUNTZE, fam. theaceae) 
 
1.5.1 General aspects 
Tea, beside water, is one of the most consumed beverages in the world. According to the 
different manufacturing processes, teas can be classified into three types: green tea (non-
fermented tea), black tea (fermented tea), and oolong tea (semi-fermented tea). The raw 
material of all of these teas are the leaves of the tea plant Camellia sinensis and its varieties. 
During fermentation, a series of complex chemical reactions takes place; the most important 
one representing the oxidation of polyphenols. This results in the formation of theaflavins, 
thearubigins, and other oxidized-polymerised compounds, which are responsible for the 
characteristic colour and flavour of black tea (Balentine et al., 1997). Unfortunately, this 
process was misleadingly termed “fermentation”, although it is mediated by cellular enzymes 
like phenol oxidase without the involvement of bacteria. For the production of green tea, the 
fermentation is prevented by heat treatment of the fresh leaves of Camellia sinensis (L.) O. 
KUNTZE. 
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In the past, green tea had an official state of medicine in several European Pharmacopoeias, 
including Ph.Port. IV, Ph.Franç. VIII-X, BP Edition 1968 and Ph.Helv. V, whereas nowadays, 
green tea is not listed in the Ph.Eur. (Netsch and Numao, 2001). Independently, in France 
green tea pharmaceuticals have been approved as drugs on the basis of the Ph. Franç. and 
the French Gazette for Marketing Authorisation of Plant Medicines (1990). Recently, cases of 
hepatic attack after the use of hydroalcoholic extracts of green tea in complement of reducing 
diets have been reported in France and Spain (Seddik et al., 2001). These observations have 
led to a suspension of the marketing authorisation of these products in both countries 
(www.who.int/medicines/library/pnewslet/3news2003.pdf). No marketing authorisation for 
medicinal use is available in other EC countries, but there exist preparations on the base of 
green tea as supplementary food. 
The French Gazette for Marketing Authorisation of Plant Medicines (1990) listed some 
traditional indications of green tea: For oral use, 1) diuresis, 2) mild diarrhoea, 3) recovery from 
fatigue, and 4) dietary supplement for weight reduction and for external use, 1) calm for itching 
of skin ailment and 2) treatment of cracks, grazes, and insect bites, etc. (Ministère des affaires 
sociales et de la solidarité, 1990). 
The composition of constituents of a green tea infusion is highly dependent on the amount of 
used tea leaves, on the extraction time, and on the quality of water used for extraction. 
Therefore, the composition can be subject to a strong variance within a certain range (Figure 
1.1). The traditional preparation of green tea as an infusion contains a broad spectrum of 
components of the drug. In general, green tea contains about 30% (w/w) of catechins in the 
dry leaves (Graham, 1992). The major catechins are epigallocatechin-3-gallate (EGCG), (-)-
epigallocatechin (EGC), (-)-epicatechin (EC), and (-)-epicatechin-3-gallate (ECG), which 
comprise more than 60% of the total catechins (Figure 1.2) (Yang and Koo, 1997). Other 
green tea constituents are the flavonols (quercetin, kaempferol, and rutin), caffeine, phenolic 
acids, the green tea specific amino acid theanine, and flavour compounds such as (Z)-3-
hexenols and its esters (Graham, 1992). 
After oral administration green tea catechins are well absorbed (Yang et al., 1998a). Catechins 
are then biotransformed in the liver, and presumably already in the intestine (Vaidyanathan et 
al., 2002; Zhang et al., 2004), to conjugated metabolites such as glucuronidated, methylated, 
sulfated derivatives. While EGC and EC are predominantly conjugated, EGCG is usually 
present in the free form in human plasma (Chow et al., 2001; Lee et al., 2002). Conjugates 
pass into the bile through enterohepatic circulation and might therefore reach the colon as 
glucuronides or other metabolites via this route (Scalbert et al., 2000). In the colon 
deconjugation may occur due to tissue β-glucuronidases and microflora (Aura et al., 2002; 
Kroon et al., 2004). After absorption the catechins are widely distributed to the different tissues 
with concentrations presumably not exceeding the lower micromolar to nanomolar range (0.1-
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1.0 µM) as indicated by EGCG plasma concentrations (Yang, 1997; Lee et al., 2002). 
However, due to the direct contact to the tea infusion, the gastrointestinal tract is likely to be 
exposed to higher concentrations of green tea constituents, irrespective of whether they are 
absorbed, retained, or recirculated to the gut tissues. 
 
 
 
Figure 1.1: Composition of constituents in green tea leaves (Zhen, 2002) 
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Figure 1.2: Structure and composition of the major catechins in green tea 
 
 
1.5.2 Pharmacological activities 
In recent time green tea and its components have moved into focus of scientific interest. Main 
reasons are several epidemiological observations of significantly reduced incidence of several 
human cancers and cardiovascular diseases in populations with a high consumption of green 
tea (Imai et al., 1995; Imai et al., 1997). Due to the high transition into the green tea infusion, 
the good bioavailability, as well as the strong antioxidative properties, the main focus of 
research has been laid on the major catechins (Figure 1.2). Nevertheless, it has been shown 
that the effects of the multicomponent system green tea seem to be superior to those of single 
green tea components (see Chapters 3, 4, 6), what might be explained by cumulative and/or 
complementary effects of single components. Besides the catechins, the green tea 
components theanine and caffeine have been of specific interest in anti-tumour research 
(Huang et al., 1997; Sugiyama et al., 1999). 
Various population studies have shown that consumption of green tea reduces the risk of 
cardiovascular diseases (Kono et al., 1992; Imai et al., 1995). This suggests that green tea 
components exert an important role in protecting cells and tissues against oxidative damage 
mediated by free oxygen radicals. Accordingly, in a study on oxidative stress in smokers and 
non-smokers a reduction of oxidative DNA damage, lipidperoxidation, and free radical 
generation has been reported after consumption of green tea (Klaunig et al., 1999). Several in 
vitro studies have designated the green tea catechins as mainly responsible due to their strong 
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antioxidant and metal-chelating properties (Kondo et al., 1999; Kostyuk et al., 2000; Hider et 
al., 2001). Additionally, observations in vivo and in vitro give evidence that green tea may 
enhance endogenous antioxidant defences of the cell (Khan et al., 1992; Benzie et al., 1999; 
Mueller-Klieser et al., 2002). 
Cancer is one of the most widespread causes of death in the industrialized countries. 
Therefore, epidemiologic reports of a significantly reduced incidence of different cancer types 
in populations with a large frequent green tea consumption have indicated green tea as a 
potential candidate for cancer chemoprevention and anticancer therapy (Nakachi et al., 1999; 
Fujiki, 2000). As oxidants can induce cell division and DNA mutations (Ames et al., 1990; 
Cerutti, 1991), the antioxidative potential of green tea represents an important protective 
mechanism. Moreover, green tea may act via inhibition of enzyme expression and activity 
and/or modulation of signal transduction pathways. Recently, EGCG was shown to be an 
inhibitor of dihydrofolate reductase activity in vitro, which may represent a mechanism of the 
proapoptotic activity of green tea in cancer cells against normal cells (Navarro-Peran et al., 
2005). Another mechanism may be the reported differential inhibition of the antiapoptotic 
transcription factor NF-κB by EGCG in cancer versus normal cells (Ahmad et al., 2000). 
However, the inhibition of the activation of several onco-transcription factors, including NF-κB 
and AP-1, by EGCG has been reported (Bode et al., 2004). Additionally, EGCG seems to 
inhibit cell cycle progression in tumour cell lines and angiogenesis (Yang et al., 1998b; 
Mueller-Klieser et al., 2002; Cao et al., 1999; Garbisa et al., 1999). Taking these effects into 
consideration, evidence is given that green tea may act on the different stages of 
tumourgenesis, namely initiation, promotion, and progression, which emphasises its potential 
chemopreventive and anticancer activity. 
Besides cancer, cardiovascular diseases represent the main fatal diseases of humans 
worldwide. Of the cardiovascular diseases, atherosclerosis is one of the most prevalent. As 
oxidation plays a central role in the development of atherosclerosis much attention has been 
laid on antioxidants including green tea. While an inverse relation between tea consumption 
and cardiovascular risk has been described by several epidemiologic studies (Hertog et al., 
1993; Sesso et al., 1993; Kono et al., 1992; Imai et al., 1995), other studies suggested no 
beneficial effect (Vita, 2003). Green tea may exert protective effects via an inhibition of lipid 
peroxidation due to its radical scavenging activity (Terao et al., 1994; Yang et al., 1999). 
Beside lipid peroxidation, the development of thrombosis is promoted by proteases secreted 
by macrophages such as matrix metalloproteinases (Libby et al., 1999). An inhibition of matrix 
metalloproteinases by green tea has been observed, which may result in an increased plaque 
stability (Garbisa et al., 1999; Kim et al., 2005). 
Although numerous health benefits have been proposed for the consumption of green tea, its 
effectiveness in humans remains unclear. Animal models and cell culture systems may differ 
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from the human situation as for example the used doses or concentrations of green tea often 
exceeded those consumed by humans or the plasma concentration, respectively. Mechanisms 
based on the use of such high concentrations may be relevant for cancers or chronic 
inflammations in the gastrointestinal tract but not for sites, which depend on systemic 
bioavailability. 
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2. Effect of green tea extract on reactive oxygen species 
(ROS) concentration under cell culture conditions 
 
 
2.1 Introduction 
Green tea polyphenols, particularly EGCG, are naturally occurring strong antioxidants 
(Tanaka, 2000; Higdon and Frei, 2003), but they also exhibit prooxidant properties. It has been 
suggested that prooxidant activities may be an important mechanism of the anticancer 
activities found for green tea (Malik et al., 2003; Nakagawa et al., 2002). Observations of a 
recent study showed that the addition of EGCG and other green tea constituents to tissue 
culture medium generated high levels of hydrogen peroxide (H2O2) and it was postulated that 
this might represent an artefact of cell culture (Long et al., 2000). An other study showed 
similar results, although discriminating between different EGCG concentrations, while the 
presence of cells decreased H2O2 concentrations (Dashwood et al., 2002). In contrast, it was 
also reported that at high concentrations EGCG functions as a ROS producer (100 µM and 
above), whereas at concentrations below 10 µM it exerts radical scavenging activity (Saeki et 
al., 2002). Therefore, it is important to examine the possible influence of GTE on H2O2 
concentrations in the medium under cell culture conditions. To determine whether potential 
effects of GTE in future experiments might be a direct effect of GTE or an indirect effect of 
H2O2 generated as an artefact, H2O2 concentrations were determined under various 
experimental conditions. 
 
 
2.2 Materials and methods 
Materials: 
Standardized green tea special extract EFLA942 (GTE) was from Frutarom Switzerland Ltd., 
Wädenswil, Switzerland. Brief manufacturing description: After addition of 0.02% m/m Acidum 
ascorbicum, the leaves of Camellia sinensis (L.) O. KUNTZE are continuously extracted 
(percolation) with 80% (m/m) ethanol at 20-35°C. After a patented ultra-filtration process the 
crude extract is dried. The drug to extract ratio (DER) is 5.5=1. Finally, 4.6% m/m maltodextrin 
is added for content adjustment of polyphenols (49.3 % m/m), caffeine (8.46% m/m), 
theobromine (0.59% m/m), and theanine (1.73% m/m). 
 
Cell culture 
The human colon adenocarcinoma cell lines LS-180 and Caco-2 were purchased from 
American Tissue Culture Collection (ATCC, Manassas, USA) and cultured in Dulbecco’s MEM 
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(DMEM) with Glutamax-I, supplemented with 10% (v/v) fetal calf serum (FCS), 1% non-
essential amino acids, 1% sodium pyruvate and 50 µg/ml gentamycin. Per cell culture well, 106 
cells have been distributed. Only freshly prepared and filtered (0.2 µm) mixtures of GTE with 
medium were used. All cultures were maintained in a humidified 37°C incubator with 5% 
carbon dioxide in air atmosphere. All cells used in this study were between passages 40 and 
70. 
 
Measurement of H2O2 
The Amplex Red Hydrogen Peroxide Assay Kit (Molecular Probes, Leiden, The Netherlands) 
was used. This kit is based on a one-step fluorimetric method, which detects H2O2 when the 
reagent, 10-acetyl-3,7-dihydroxyphenoxazine, reacts with H2O2 in a 1:1 stoichiometry in the 
presence of horseradish peroxidase. Medium in the presence or absence of 0.01 mg/ml GTE 
was incubated for 1, 15, 30, 60, 90, or 150 min at 37°C. Caco-2 or LS-180 cells at confluence 
were incubated with or without 0.01, 0.1, or 1 mg/ml GTE for 1, 15, 30, 60, 90, or 150 min at 
37°C. Samples were either diluted 1:4 with reaction buffer according to the recommendation of 
the manufacturer or used without dilution. A 50 µl aliquot of the sample was incubated with the 
reagent mixture for 30 min at room temperature in the dark. Absorption was measured at 560 
nm. (Spectra MAX 250, Microplate Spectrophotometer, Molecular Devices Corporation, 
California, USA). 
 
 
 
Figure 2.1: Time-dependent generation of H2O2 in the medium with or without 0.01 mg/ml GTE in the absence of 
cells. Samples have been analysed with or without previous 1:4 dilution. This figure is a representative of three 
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independent replications of the experiment, each with similar results. Data represents the mean values (±SEM) of 
one experiment (n=3). 
 
 
Figure 2.2: Time-dependent effect of different GTE concentrations on the generation of H2O2 in the medium in the 
presence of Caco-2 cells. This figure is a representative of three independent replications of the experiment, each 
with similar results. Data represents the mean values (±SEM) of one experiment (n=3). 
 
 
 
Figure 2.3: Time-dependent effect of different GTE concentrations on the generation of H2O2 in the medium in the 
presence of LS-180 cells. This figure is a representative of three independent replications of the experiment, each 
with similar results. Data represents the mean values (±SEM) of one experiment (n=3). 
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2.3 Results and discussion 
Our present findings indicate that GTE in a concentration range of 0.01 to 1 mg/ml does not 
significantly increase H2O2 concentrations in DMEM in the presence of Caco-2 (Figure 2.2) or 
LS-180 (Figure 2.3) cells over a time range of 150 min. The results differ from recent 
publications, where the green tea component EGCG was shown to generate H2O2 in cell 
culture (Yang et al., 2000; Dashwood et al., 2002). However, it has to be noted that human 
bronchial epithelial cells grown in LHC-9 medium or HEK293 cells grown in DMEM were used 
in these studies, whereas in our study Caco-2 or LS-180 cells grown in DMEM were used. 
Importantly, GTE did not significantly modulate H2O2 concentrations in the absence of cells in 
a time range of 150 min (Figure 2.1), which was in accordance to results observed for EGCG 
in the same medium (Dashwood et al., 2002). 
Further investigation of the effect of EGCG on H2O2 generation in our experimental system 
would have been interesting for a determination of the impact of different cell types, no matter 
if derived from the same tissue (Hong et al., 2002) or not (Yamamoto et al., 2003), on the pro-
oxidative activity of EGCG. Additionally, this might have clarified if, in case of a prooxidative 
effect of EGCG as described in the literature, other green tea components in GTE might 
scavenge H2O2 generated by EGCG, what would have given an explanation on our findings. 
However, basal H2O2 levels found in the cell culture medium in the absence or presence of 
Caco-2 or LS-180 cells were relatively high with concentrations about 120 µM. 
In summary, we did not observe an impact of GTE, in the concentration range used, on H2O2 
concentrations in the cell culture medium in the presence or absence of Caco-2 or LS-180 
cells. In accordance to chemopreventive effects of EGCG described in the literature 
(Yamamoto et al., 2004), this excludes that the effects of GTE described in Chapters 3-6 are 
based on H2O2 generation by GTE. 
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3. Inhibitory activity of a green tea extract and some of its 
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3.1 Abstract 
Green tea extracts (GTE) might modulate ABC transporter gene expression or function. This 
may be relevant in treatment of cancer or in influencing intestinal drug permeability. To gain 
more insight on the influence of a GTE on secretory transport proteins we investigated the 
influence of GTE and several green tea components on the mRNA expression level of P-
glycoprotein (P-gp) and multidrug resistance-associated protein 2 (MRP2) in human 
gastrointestinal epithelial LS-180 cells. Furthermore, functional activity of MRP2, using 
glutathione methylfluorescein (GS-MF) or [3H]methotrexate (MTX) as substrate, was 
investigated in canine kidney cells stably overexpressing human MRP2 (MDCK-MRP2). GTE, 
at a concentration of 0.01 mg/ml, did not increase mRNA expression of P-gp or MRP2 in LS-
180 cells. Functional assays in MDCK-MRP2 cells using GS-MF did not show any effect of 
0.01 mg/ml GTE on MRP2 activity. In the same cell line the cellular accumulation of MTX (a 
specific substrate of MRP2) was significantly increased with the MRP-specific inhibitor MK-571 
or with 1 mg/ml GTE, but not with 0.1 mg/ml. The green tea components (-)-epigallocatechin 
gallate, (-)-epigallocatechin, theanine, or caffeine, each in corresponding concentrations to the 
respective concentration of GTE, did not show any effect on MRP2 function. These data 
demonstrated that the mRNA expression patterns of P-gp and MRP2 in LS-180 cells are not 
altered by 0.01 mg/ml of GTE. However, MRP2 function was inhibited by 1 mg/ml GTE, 
whereas none of the green tea components tested were responsible for this effect. 
 
 
3.2 Introduction 
Transmembrane transport proteins play a crucial role for the maintenance of the barrier 
function of the intestinal epithelium, which is critical for the disposition as well as the 
cytotoxicity of xenobiotics. Accordingly, enterocyte derived cell lines, such as LS-180 cells, are 
provided with different transport systems including the ATP-binding cassette (ABC) 
transporters P-glycoprotein (P-gp) and the multidrug resistance protein (MRP) family 
(Gottesman and Pastan, 1993; Ambudkar et al., 1999; Borst et al., 2000; Keppler et al., 1997). 
P-gp, which is encoded by the MDR1 gene, is located in the apical membrane of enterocytes 
and acts as an efflux pump that extrudes many clinically important drugs thereby limiting their 
oral bioavailability (Kim et al., 1998; Greiner et al., 1999). Multidrug resistance-associated 
protein 2 (MRP2) is localized in the apical membrane of polarized cells and transports various 
glutathione S-conjugates and several anticancer drugs including methotrexate (König et al., 
1999; Evers et al., 1998; Cui et al., 1999; Hooijberg et al., 1999; Fujiki, 1999). 
Green tea is one of the most popular beverages worldwide and several beneficial/protective 
effects on life-style related diseases, including anticarcinogenic activities, are being attributed 
to its consumption (Fujiki, 1999; Kostyuk et al., 2000). Due to the increasing use of green tea 
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preparations as food supplements or drugs, possible influences on drug transporter systems 
have to be assessed.  Recently, some green tea polyphenols, namely (-)-epigallocatechin 
gallate (EGCG), (-)-epicatechin gallate, and (-)-catechin gallate, have been shown to interact 
with P-gp and to inhibit its function (Jodoin et al., 2002), whereas for (-)-epicatechin a 
concentration-dependent functional activation of P-gp was reported (Wang et al., 2002). Other 
green tea components are able to inhibit the efflux of the anticancer drug doxorubicin (DOX), a 
substrate of P-gp and MRP2 (Ambudkar et al., 1999; Borst et al., 2000; Sadzuka et al., 1998; 
Sadzuka et al., 2000). 
Thus, GTE might modulate ABC transporter gene expression or function. This may be relevant 
in treatment of cancer or in influencing intestinal drug permeability. Therefore, this study 
focused on the effect of GTE on P-gp or MRP2 mRNA expression in cultured intestinal LS-180 
cells and on the influence of GTE or different green tea components (Figure 3.1) on MRP2 
functional activity. 
 
 
 
 
Figure 3.1: Chemical structures of GTE components epigallocatechin gallate (EGCG), epigallocatechin (EGC), 
caffeine, and theanine. 
 
 
 35
3.3 Materials and Methods 
Materials  
Standardized green tea special extract EFLA942 (GTE) was from Frutarom Switzerland Ltd., 
Wädenswil, Switzerland. Brief manufacturing description: leaves of Camellia sinensis (L.) O. 
KUNTZE are continuously extracted (percolation) with 80% (m/m) ethanol. After a patented 
filtration process (US 6024998) the crude extract is dried. Finally, 5% m/m maltodextrin is 
added as carrier. The drug to extract ratio (DER) is 5.5=1. Characteristic components in the 
extract are polyphenols (47.5-52.5% m/m), caffeine (5.0-10.0% m/m), theobromine (0.30-
1.20% m/m), and theanine (1.0-3.0% m/m). (-)-Epigallocatechin gallate (EGCG) was from 
CHEMOS GmbH, Regenstauf, Germany, (-)-epigallocatechin (EGC) was from Sigma-Aldrich 
Chemie GmbH, Steinheim, Germany. In the batch used the following concentrations of 
constituents in 0.01 mg/ml GTE were determined: 4.02 µM EGCG; 2.27 µM EGC; 4.36 µM 
caffeine; 0.99 µM theanine. MK-571 was from Biomol, Plymouth Meeting, PA, USA. 
Chloromethylfluorescein-diacetate (CMFDA) was from Molecular Probes, Eugene, OR, USA; 
[3H]methotrexate (MTX) was from Movarek Biochemicals, CA, USA; [14C]sucrose was from 
Amersham, UK. All other chemicals were obtained from commercial sources in the highest 
quality available. 
 
Cell cultures 
The human colon adenocarcinoma cell line LS-180 was purchased from American Tissue 
Culture Collection (ATCC, Manassas, USA) and cultured in Dulbecco’s MEM with Glutamax-I, 
supplemented with 10% (v/v) fetal calf serum (FCS), 1% non-essential amino acids, 1% 
sodium pyruvate and 50 µg/ml gentamycin; Madin Darby canine kidney (MDCK) cells stably 
overexpressing human MRP2 (MDCK-MRP2) were a kind gift from Dr. Evers (The Netherlands 
Cancer Institute, Amsterdam, Netherlands) and cultured in Dulbecco’s MEM with Glutamax-I, 
in the presence of 50 µg/ml gentamycin. Per cell culture well, 106 cells have been distributed. 
All cultures were maintained in a humidified 37°C incubator with 5% carbon dioxide in air 
atmosphere.  
 
Colorimetric cytotoxicity assay 
Cytotoxicity of GTE was screened in LS-180 or MDCK-MRP2 cells at confluence. LS-180 cells 
were incubated for 72 hours in the absence or presence of 0.001, 0.003, 0.01, 0.03, 0.1, 0.3, 
1, and 3 mg/ml GTE, respectively. MDCK-MRP-2 cells were incubated for 30 minutes with or 
without 0.01, 0.1, and 1 mg/ml GTE, or corresponding concentrations (4.02, 40.2, and 402 µM) 
of EGCG. Replacement with medium containing the compound of interest was done every 24 
h. Only freshly prepared and filtered (0.2 µm) mixtures of GTE with medium were used. 
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Cultures fixed with trichloroacetic acid were stained for 30 minutes with 0.4 % sulforhodamine 
B (SRB) dissolved in 1 % acetic acid. Unbound dye was removed by washing four times with 
1% acetic acid and protein bound dye was extracted with 10 mM Tris buffer. Absorption was 
measured at 540 nm. (Spectra MAX 250, Microplate Spectrophotometer, Molecular Devices 
Corporation, California, USA) (Skehan et al., 1990). SRB absorption intensity correlates 
linearly with the number of living cells. 
 
Real time polymerase chain reaction (TaqMan assay) 
For mRNA induction experiments LS-180 cells at confluence were incubated either with or 
without 10 µM rifampicin or with 0.01 mg/ml GTE for 72 h. Replacement with freshly prepared 
medium containing the compound of interest took place every 24 hours. 
After removal of the medium at the end of the culture period, the cells were treated with lysis 
buffer RLT (Qiagen) and 1 % β-mercaptoethanol (Sigma, St. Louis, USA) was added. The total 
amount of RNA was extracted by using the RNeasy™ Mini Kit (Qiagen, Hilden, Germany) 
according to the manufacturer’s protocol. RNA concentration was measured with a Gene 
Quant photometer (Pharmacia, Uppsala, Sweden). The purity of the RNA preparations was 
high, as demonstrated by the 260/280 nm ratio (range 1.7 to 2.0). DNA was digested by using 
the DNA-Digestion Kit with DNase I Amplification Grade, 10x DNase I Reaction Buffer and 
25mM EDTA (Invitrogen, Life technologies Basel, Switzerland) according to the manufacturers’ 
protocol. 
2 µg of total RNA was reverse transcribed to cDNA by using SuperScript TM II RT, 0.1 M DTT, 
5x Strand Buffer, oligonucleotides (Invitrogen, Life technologies) and Random Hexamer 
(Applied Biosystems, Rotkreuz, Switzerland). Reverse transcription was done according to the 
manufacturers’ protocol. 
For DNA-Digestion as well as for reverse transcription the Eppendorf Mastercycler Personal 
heating cyclometer was used. 
All RNA isolation procedures and reverse transcriptions were performed under RNase free 
conditions (RNeasy Erase Spray, ICN Biochemicals, Inc. Ohio, USA), freshly prepared water 
from highest quality was used (Milli Q, 18.2 mOhm, Kantonsspital Basel, Switzerland). 
25 ng of complementary DNA was used as a template for real time quantitative PCR analysis. 
The cDNA was amplified in a 25 µl volume containing Master-Mix (TaqMan®Universal PCR 
Master Mix, Applied Biosystems, USA), water, forward primer, reverse primer (Eurogentec, 
Seraing, Belgium) and probe (Invitrogen, Basel, Switzerland) mixed according to the 
manufacturers’ protocol. 
The assay was performed using a Gene Amp 5700 Sequence Detector (Applied Biosystems, 
Rotkreuz, Switzerland), which combines a thermocycler and a fluorescence detector. Each 
sample of the reaction mixture was amplified during 40 cycles (15 sec at 90°C, 1 min at 60°C). 
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As a negative control not-transcribed total RNA was used. For P-gp detection the following 
primers and probe were used: 5`-AAGCTGTCAAGGAAGCC-AATGCCTATGACTT-3` (probe), 
5`-CTGTATTGTTTGCC ACCACGA-3` (forward), and 5`-
AGGGTGTCAAATTTATGAGGCAGT-3` (reverse). For MRP2 detection the following primers 
and probes were used: 5`-CTCAATATCACACAAACCCTGAACTG-GCTG-3` (probe), 5`-
ACTGTTGGCTTTGTT CTGTCCA-3` (forward), and 5`-CAACA-GCCACAATGTTGGTCTCTA-
3` (reverse). 
A relative standard curve was generated by serial dilutions of cDNA. Fragments of cDNA 
corresponding to MDR1 and MRP2 that covered the TaqMan primer/probe area were obtained 
by PCR amplification. All of the DNA standards were quantified using the Pico Green reagent 
(Molecular Probes). For absolute quantification, Ct values of standards were plotted against 
the log of the respective dilution factors. Slope and y-intercept of the standard curve line were 
then calculated by linear regression. Each standard curve was generated from a known 
amount of corresponding cDNA and was then used to calculate the input amount for unknown 
samples for respective genes. Absolute quantification was done for every experiment. 
 
Autofluorescence and Quenching 
Changes of fluorescence intensity of the transport buffer Hank’s Balanced Salt Solution 
(HBSS, Gibco, Basel, Switzerland) were analysed without cells in the presence of 0.01, 0.1 or 
1 mg/ml GTE or the corresponding concentrations of EGCG, EGC, theanine or caffeine. 
Changes in fluorescence of a fixed methylfluorescein (MF) concentration of 50nM were 
analysed in the presence of 0.01, 0.1 or 1 mg/ml GTE or the corresponding concentrations of 
EGCG, EGC, theanine or caffeine. Experiments were performed at room temperature. 
Fluorescence was measured with a HTS 7000 Plus Bio Assay Reader (Perkin Elmer Ltd., 
Buckinghamshire, UK). 
 
Functional Assays 
Functional assays for MRP2 transport were performed at 37°C using confluent monolayers of 
MDCK-MRP2 cells, which were grown in 24-well cell-culture plates. Cells were washed twice 
with HBSS. 
In the assays using CMFDA as substrate, cells were preincubated with 10 µmol/l CMFDA for 1 
hour at 10 °C. Thereafter cells were washed twice with ice-cold HBSS and kept at 10°C in 
HBSS with 10 % sodium pyruvate. CMFDA is metabolised in the cells to glutathione-
methylfluorescein (GS-MF). Then, GS-MF efflux from the cells was measured at 37°C by 
incubating with medium containing 10% sodium pyruvate in the absence or presence of 20 µM 
MK-571, 0.01 mg/ml GTE, or corresponding concentrations of EGCG, EGC, theanine, or 
caffeine in concentrations corresponding to 0.01, 0.1, or 1 mg/ml GTE. After 5, 10, 15, 20, 25 
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and 30 minutes, 200µl samples were removed and fluorescence was measured with a HTS 
7000 Plus Bio Assay Reader (Perkin Elmer Ltd., Buckinghamshire, UK). Cellular accumulation 
after 30 minutes was assessed by lysing the cells with 1% Triton X-100 in PBS and 
fluorescence determination of the cell homogenate. 
Using MTX as substrate, cells were washed twice with HBSS and preincubated without tracers 
in the presence or absence of 20 µM MK-571, 0.1 or 1 mg/ml GTE, or the corresponding 
concentrations of EGCG for 10 minutes at 37°C. Then cells were incubated under the same 
conditions in the presence of 11.8 µM MTX (0.3 µCi) and 488 µM [14C]sucrose  (0.3 µCi) for 30 
minutes at 37°C. For the quantification of the cellular accumulation of MTX and [14C]sucrose 
the cells were lysed with trypsin-EDTA and transferred to a vial containing 3 ml of scintillation 
cocktail (Insta-Gel, Packard Instrument B.V., NL). Finally, radioactivity was measured. 
 
Data analysis 
For statistical comparison, data of groups were compared by analysis of variance (ANOVA). 
The level of significance was P = 0.05. If this analysis revealed significant differences, pairwise 
comparisons within groups were performed by two-sided unpaired t-tests. P-values were 
adjusted by Bonferroni's correction for multiple comparisons. 
 
 
3.4 Results 
Cytotoxicity assay with LS-180 cells was performed to determine the concentration range of 
GTE without toxic effects (Figure 3.2a). Significant toxic effects were observed at 0.3 mg/ml 
GTE. Since toxicity itself might influence the expression level of transport proteins, it is 
important, that GTE concentrations used in mRNA expression studies exhibit no cellular 
toxicity. None of the GTE or EGCG concentrations exhibited toxicity on MDCK-MRP2 cells 
after incubation for 30 minutes (Figure 3.2b). 
At confluence, LS-180 cells were incubated for 72 h with medium only, 10 µM rifampicin or 
with 0.01 mg/ml GTE. Quantitative real time PCR was performed to determine the mRNA 
expression of MDR1 and MRP2. Rifampicin showed a significant induction of MDR1 mRNA 
expression, whereas GTE did not alter MDR1 mRNA levels. MRP2 mRNA expression was not 
influenced by GTE. Unfortunately, rifampicin did not serve as a positive control and elevated 
MRP2 mRNA expression only slightly but not significantly (Figure 3.3). 
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Figure 3.2: Dose-dependent toxicity of GTE in LS180 cells over 72 h (a) and MDCK-MRP2 cells over 30 min (b) 
using sulforhodamine B assay. Data represent mean values (± SEM) of 5 experiments. (* statistically significant 
different from control values, p < 0.05). 
 
 
 
Figure 3.3: Relative mRNA expression of MDR1 (a) and MRP2 (b). Transcriptional expression was determined in 
LS-180 cells by quantitative real-time PCR. Cells were treated for 72h with medium only (black bars), or with either 
10 µM rifampicin (dark grey bars) or with 0.01 mg/ml GTE (light grey bars). mRNA expression was relative to the 
respective control. MDR1 (n=3) data were generated in triplicate, MRP2 data represents the pooled results of 3 
separate experiments (n=3). (* statistically significant difference, p < 0.05). Data represent means ± SEM. 
 
 
To investigate the influence of GTE or the green tea components EGCG, EGC, theanine, or 
caffeine on the transport activity of MRP2, kinetic assays were performed in MDCK-MRP2 
cells overexpressing MRP2. The cells were loaded with CMFDA, which is metabolised to 
glutathione-methylfluorescein (GS-MF), a specific substrate of MRP2. MK-571, a specific 
MRP-inhibitor, significantly increased the cellular accumulation of GS-MF, indicating a 
blockage of MRP2 function by MK-571. The cellular accumulation of GS-MF was not altered 
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by 0.01 mg/ml GTE or corresponding concentration of EGCG  (Figure 3.4a-b). These results 
were confirmed by measurement of the extrusion of GS-MF, which was significantly decreased 
after treatment with MK-571, whereas 0.01 mg/ml GTE or the corresponding concentration of 
EGCG did not alter the extrusion of GS-MF in a relevant manner (Figure 3.4c-d). 
Concentrations of EGC, theanine or caffeine corresponding to 0.01, 0.1 and 1 mg/ml GTE 
showed no effect on GS-MF accumulation (Figure 3.5a-c). 
 
 
 
 
 
Figure 3.4: Accumulation of GS-MF in MDCK-MRP2 cells after incubation for 30 minutes at 37°C with medium 
only, with 20 µM MK-571, or either with GTE or corresponding concentration of EGCG (a-b). Time-dependent efflux 
at 37°C of GS-MF by MDCK-MRP2 cells during incubation with medium only, with 20 µM MK-571, or either with 
GTE or corresponding concentration of EGCG (c-d). (* statistically significant difference, p < 0.05). Data represent 
means ± SEM. 
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Figure 3.5: Accumulation of GS-MF in MDCK-MRP2 cells after incubation for 30 minutes at 37°C with medium 
only, with 20 µM MK-571, or either with EGC (a), theanine (b) or caffeine (c) in corresponding concentrations as in 
0.01, 0.1, or 1 mg/ml GTE. (* statistically significant difference, p < 0.05). Data represent means ± SEM. 
 
 
Due to significant autofluorescent activity of GTE at concentrations 0.1 and 1 mg/ml as well as 
significant quenching activities of 0.1 and 1 mg/ml GTE or corresponding EGCG 
concentrations with GS-MF (data not shown), functional assays in MDCK-MRP2 cells with 
these concentrations were performed with MTX as substrate (Figure 3.6). Therefore, cells 
were incubated with MTX, which is transported out of the cell via MRP2 but not via P-gp. MK-
571 significantly decreased the efflux of MTX. GTE, at a concentration of 1 mg/ml, significantly 
increased the cellular accumulation of MTX by a factor of 1.7, suggesting a functional inhibition 
of MRP-2. Neither the corresponding concentration of EGCG nor the lower concentration of 
GTE or EGCG exerted an influence on MRP2 activity. The integrity of the monolayer barrier 
was not affected in these experiments as demonstrated by the measurement of [14C]sucrose 
transport. 
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Figure 3.6: Cellular accumulation of MTX and [14C]sucrose in MDCK-MRP2 cells after incubation for 30 minutes at 
37°C with medium only, with 20 µM MK-571, or either with GTE or corresponding concentrations of EGCG. (* 
statistically significant difference, p < 0.01). Data represent means ± SEM. 
 
 
3.5 Discussion 
Intestinal cellular drug availability might be strongly modulated by P-gp and MRP2 function. 
Both are abundantly expressed in intestinal epithelial cells and show partly overlapping 
substrate specificities (Luo et al., 2002; Marbeuf-Gueye et al., 1998). The antibiotic rifampicin 
has been shown to significantly increase intestinal MDR1 and MRP2 expression (Greiner et 
al., 1999; Fromm et al., 2000). To investigate induction of MDR1 mRNA expression, LS-180 
cell line has been shown to be a suitable model (Schuetz et al., 1996; Pfrunder et al., 2003). 
However, induction of MRP2 has not been demonstrated yet. Recently, inhibitory effects on P-
gp function by green tea components have been reported in the literature (Jodoin et al., 2002; 
Sadzuka et al., 2000), whereas no data about the influence of green tea on MRP2 is available 
yet. Therefore, this study was designed to investigate the influence of GTE on the expression 
pattern of MDR1 and MRP2 as well as to examine the potential effect of GTE and several 
green tea components on the functional activity of MRP2. 
Cytotoxicity assay demonstrated that 0.01 mg/ml GTE was in the non-toxic range for LS-180 
cells after an incubation for 72h. Thus, artefacts of mRNA induction experiments due to cellular 
detoxification activities were prevented. No significant induction of MDR1 or MRP2 mRNA 
expression by GTE was observed in LS-180 cells. Regarding the influence on MRP2 protein 
functionality in MDCK-MRP2, neither 0.01 to 0.1 mg/ml GTE nor the green tea components 
EGCG, EGC, caffeine, or theanine, each in corresponding concentrations to GTE, exerted any 
appreciable influence on the MRP2-mediated export in comparison to the MRP-specific 
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inhibitor MK-571. At a concentration of 1 mg/ml, GTE significantly inhibited MRP2 activity, 
whereas the green tea components used above did not show any effect. All GTE 
concentrations used for MDCK-MRP2 cells were in the non-toxic range. 
In brief, 0.01 mg/ml GTE did not modulate mRNA expression of MRP2 or MDR1 in intestinal 
epithelial LS-180 cells. Therefore, our results indicate, that neither the intestinal absorption 
through MRP2 nor through P-gp is altered by a change in gene transcription by 0.01 mg/ml 
GTE. The efflux of MRP2-substrates including GS-MF and MTX was inhibited only at a high 
concentration of 1 mg/ml GTE. EGCG is the principal catechin in green tea and most of the 
effects associated with green tea might be mediated by this catechin. It is tempting to 
speculate, that other green tea components except EGCG, EGC, caffeine, or theanine are 
responsible for the demonstrated inhibition of MRP2 function. 
 
Acknowledgements 
We are thankful to U. Behrens for excellent technical assistance. This work was supported by 
an unconditional research grant of Frutarom Switzerland Ltd., 8820 Waedenswil, Switzerland. 
 44
 
 
 
4. Induction of CYP1A by green tea extract in human 
intestinal cell lines 
 
 
 
 
 
 
1,2Marco I. Netsch, MSc, 1Heike Gutman PhD, 2Caesar B. Schmidlin PhD, 2Cem Aydogan MD 
PhD, 1Juergen Drewe MD, MSc. 
 
 
1 Department of Gastroenterology and Department of Research, University Clinic Basel 
/Universitätsspital Basel, CH-4031 Basel, Switzerland 
 2Frutarom Switzerland Ltd., R&D Dept. Phytopharmaceuticals, Waedenswil, Switzerland 
 
 
 
 
 
 
Planta Medica 
submitted, 2005 
 45
4.1 Abstract 
In this study the influence of green tea extract (GTE) or its component epigallocatechin gallate 
(EGCG) on the expression of different cytochrome P450 (CYP) isoenzymes was investigated 
in the human gastrointestinal epithelial cell lines LS-180 and Caco-2. Additionally, the effect of 
GTE or EGCG on functional activity of different CYP isoenzymes was investigated in vitro. 
mRNA expression levels were determined by quantitative RT-PCR and compared with protein 
levels. In LS-180 cells GTE, but not EGCG, significantly induced CYP1A2 mRNA expression, 
whereas neither CYP1A1 nor CYP3A4 mRNA expression was modulated by GTE or EGCG. In 
Caco-2 cells CYP1A1 as well as CYP1A2 mRNA expression was significantly increased in a 
dose-dependent manner by GTE and EGCG. However, EGCG alone was about 3-5 fold less 
effective than GTE. mRNA expression of CYP1A1 or CYP1A2 induced by the promutagen 
benzo[a]pyrene was significantly down-regulated by EGCG but not by GTE. CYP1A protein 
levels in response to GTE in Caco-2 and LS-180 cells confirmed the mRNA expression results. 
CYP activity was measured with CYP1A2 or CYP3A4 expressed in insect cell membranes 
using a luminescent method. GTE or EGCG significantly inhibited CYP1A2 and CYP3A4 
function in a dose-dependent manner. Therefore, it appears that green tea moderately 
modulates the expression of drug-metabolising enzymes but non-specifically inhibits the 
function of human CYPs. Since CYP enzymes play an important role in detoxification 
processes, these results might be of relevance concerning chemopreventive strategies using 
GTE. 
 
 
4.2 Introduction 
Cytochrome P450 (CYP) enzymes play a pivotal role in detoxification processes of the cell by 
metabolising xenobiotics. The cellular detoxification potential can be modulated by xenobiotics 
through induction of CYP expression or their inhibition. Hence, to assess the potential of a 
drug to interact with detoxification processes, early in vitro experiments are desirable. The 
mucosa of the small intestine represents an important determinant of drug metabolism due to 
the capability of metabolising orally ingested xenobiotics prior to systemic uptake (Kaminsky 
and Zhang, 2003). Accordingly, widely used intestinal in-vitro models, such as Caco-2 or LS-
180, are equipped with different cytochrome P450 (CYP) isoforms including CYP1A1, 
CYP1A2, and CYP3A4 (Borlak and Zwadlo, 2003; Schmiedlin-Ren et al., 1997; Li et al., 1998; 
Schuetz et al., 1996). The principal CYP occurring in enterocytes, CYP3A4, has been 
associated with the metabolic elimination of many drugs, thereby substantially contributing to 
the poor oral bioavailability of some of these drugs (Hebert et al., 1992; Thummel et al., 1996). 
In humans extensive interindividual variability has been found for the intestinal expression of 
CYP1A1 and CYP1A2 (McDonnell et al., 1992; Lindell et al., 2003). Carcinogens like 
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polyaromatic hydrocarbons present in cigarette smoke and cooked meat, such as 
benzo[a]pyrene (B[a]P), as well as heterocyclic amines found in fried or grilled meats and fish 
are metabolised by CYP1A (Knize et al., 1999; Gautier et al., 1996). 
The role of green tea in cancer chemoprevention, meaning the ability to delay the onset of the 
carcinogenic process, has become an intense area of research over the past years 
(Weisburger and Chung, 2002). Protection against polyaromatic hydrocarbon-induced cancers 
by green tea has been demonstrated in different animal models (Katiyar et al., 1993; Xu et al., 
1996). 
In this study, the two colon carcinoma-derived cell lines Caco-2 and LS-180 were used. In both 
cell lines induction of xenobiotic metabolising enzymes by possibly carcinogenic xenobiotics 
has been shown (Borlak and Zwadlo, 2003; Li et al., 1998). LS-180 cells represent a more 
suitable model to investigate the inducibility of CYP3A4 by rifampicin than Caco-2 cells 
(Pfrunder et al., 2003). 
The present study was undertaken to investigate whether green tea extract (GTE), or its major 
constituent epigallocatechin gallate (EGCG) (Figure 3.1), modulate the mRNA expression of 
intestinal CYP1A or CYP3A4. This was conducted by quantitative RT-PCR. Western blot 
analysis was performed to correlate CYP1A protein expression with the results from mRNA 
expression experiments. For comparative reasons two different human intestinal cell lines 
were used. Additionally, the implication of simultaneous treatment with B[a]P and GTE or 
EGCG on CYP1A mRNA expression was examined in Caco-2 cells. Finally, the influence of 
GTE or EGCG on CYP1A2 or CYP3A4 function was investigated using a luminescent method. 
Insight into the inducibility and functional inhibition of different human intestinal CYP isoforms 
by GTE might provide important information concerning dietary interactions with the human 
intestinal xenobiotic metabolism. 
 
 
4.3 Materials and Methods 
Materials  
Standardized green tea special extract EFLA942 (GTE) produced of the leaves of Camellia 
sinensis (L.) O. KUNTZE was from Frutarom Switzerland Ltd., Wädenswil, Switzerland. The 
manufacturing process has been described before (Chapter 2.2). (-)-Epigallocatechin gallate 
was from CHEMOS GmbH, Regenstauf, Germany. Benzo[a]pyrene and rifampicin were from 
Sigma, Switzerland. Furafylline and ketoconazole were from Becton Dickinson Ltd. Allschwil, 
Switzerland. All other chemicals were obtained from commercial sources in the highest quality 
available. 
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Cell cultures 
The human colon adenocarcinoma cell lines LS-180 and Caco-2 were purchased from 
American Tissue Culture Collection (ATCC, Manassas, USA) and cultured in Dulbecco’s MEM 
with Glutamax-I, supplemented with 10% (v/v) fetal calf serum (FCS), 1% non-essential amino 
acids, 1% sodium pyruvate and 50 µg/ml gentamycin. Per cell culture well, 106 cells have been 
distributed.  At confluence, cell cultures were used for experiments. Replacement with medium 
containing the compound of interest was done every 24h. Only freshly prepared and filtered 
(0.2 µm) mixtures of GTE with medium were used. All cultures were maintained in a humidified 
37°C incubator with 5% carbon dioxide in air atmosphere.   
 
Colorimetric cytotoxicity assay 
Cytotoxicity of GTE was screened in LS-180 or Caco-2 cells. LS-180 or Caco-2 cells were 
incubated for 72 hours in the absence or presence of 0.01, 0.05, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 
0.45, 0.5, and 1 mg/ml GTE, or corresponding concentrations (4.02, 20.1, 40.2, 60.3, 80.4, 
100.5, 120.6, 140.7, 160.8, 180.9, 201, and 402 µM) of EGCG. The sulforhodamine B assay 
used for the measurement of cytotoxicity has been described before (Chapter 3.1.3). 
 
Real time polymerase chain reaction (TaqMan assay) 
For mRNA induction experiments, LS-180 cells at confluence were incubated either with or 
without 10 µM rifampicin or 10 µM B[a]P, or with 0.1, 0.25, or 0.4 mg/ml GTE, or with 40.2 or 
100 µM EGCG for 72 h. For mRNA induction experiments Caco-2 cells at confluence were 
incubated either with or without 10 µM B[a]P, with or without 0.01, 0.1, 0.25, or 0.4 mg/ml GTE, 
or with or without 4.02, 40.2 or 100 µM EGCG for 24 h. RNA extraction, reverse transcription, 
DNA digestion, and PCR amplification was performed as described elsewhere (Chapter 3.1.3). 
For CYP1A1 detection the following primers and probe were used: 5`-
CGCTATGACCACAACCACCAAGAACT-3` (probe), 5`-GTCATCTGTGCCATTTGCTTTG-3` 
(forward), and 5`-CAACCACCTCCCCGAAATTATT-3` (reverse). For CYP1A2 detection the 
following primers and probes were used: 5`-CACAGCCATCTCCTGGAGCCTCATGTA-3` 
(probe), 5`-CAATGACGTCTTTGGAGCAGGAT-3` (forward), and 5`-
CAATCACAGTGTCCAGCTCCTTC-3` (reverse). For CYP3A4 detection the following primers 
and probes were used: 5`-TTCTCCTGGCTGTCAGCCTGGTGC-3` (probe), 5`-
TCTCATCCCAGACTTGGCCA-3` (forward), and 5`-CATGTGAATGAGTTCCATATAGATAGA-
3` (reverse). 
All samples were run in triplicates and were quantified using a standard curve. Standards were 
generated by a serial dilution of PCR products of the appropriate gene. Fragments of cDNA 
corresponding to CYP1A1, CYP1A2 and CYP3A4 that covered the TaqMan primer/probe area 
were obtained by PCR amplification. To standardize the amount of sample cDNA added to the 
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reaction the calculated amount of the gene of interest was divided by the calculated amount of 
the constitutively expressed ribosomal 18S gene in the sample. These normalized amounts 
were then used to compare the relative amount of target in different samples. The expression 
level of the endogenous control gene 18S did not alter under any of the different treatments. 
 
Protein extraction 
Proteins were extracted by lysing a frozen (-20°C) cell pellet in 1ml protein extraction buffer 
(pH 7.4), containing 20 mM Tris-HCl, 0.5 mM Na3VO4 and 1 % (v/v) Igepal CA-630. Proteases 
were inhibited with 1mM PMSF, 8 µM leupeptin, 5 µM bestatin, 2 µg/ml aprotinin, 6 µM E-64 
and 1 µM pepstatin. The suspension was centrifuged at 15000 rpm for 10 min at 4°C and 
supernatant was frozen at –70°C. Protein quantification was performed with the BCA Protein 
Assay (Pierce, Rockford, Il, USA). Samples were transferred into a 96-well microtiter plate and 
UV-detection was performed with a Spectra Max 250 (Molecular Devices Corp., Sunnivale, 
CA, USA) at 562 nm and compared to a heat-shock inactivated bovine serum albumin (BSA) 
standard. 
 
Western blot 
Samples of 150 µg protein from LS-180 cells or 100 µg protein from Caco-2 cells were diluted 
1:1 with Laemmle dilution buffer and loaded on a 4% stacking and 7.5% separating acrylamide 
/ bisacrylamide gel. Electrophoresis was performed in a Mini-Protean 3 cell (BioRad 
Laboratories AG, Reinach, Switzerland) with 80 V in the stacking gel and constant 120 V in the 
separating gel for 1 h. Running buffer (pH 8.5) contained 0.25 M Tris-HCl, 1.93 M glycine and 
1% (w/v) SDS. Proteins were electrophoretically transferred to a 0.45 µm pore size pure 
nitrocellulose membrane using a Mini Trans-Blot Transfer Cell (BioRad Laboratories AG, 
Reinach, Switzerland). Transfer buffer (pH 8.3) contained 0.025 M Tris-HCl, 0.193 M glycine 
and 20 % (m/v) methanol. Blotting was performed with a constant current of 250 mA for 2.5 h 
and was controlled by staining the membrane with 0.1% ponceau S in 3% acetic acid. The 
membrane was blocked overnight at 4°C with 5% (w/v) skimmed milk powder in PBS 
containing 0.05% (v/v) Tween 20 (PBS-T). 
 
Immunodetection of CYP1A2 
Membranes were washed three times for 15 min in PBS-T and then incubated for 24 h at 4°C 
with the mouse anti-CYP1A2 monoclonal antibody (Gentest, Woburn, MA, US), diluted 1:1000 
in PBS-T containing 1% (w/v) skimmed milk powder and 1% (m/v) BSA. After washing the 
membrane as mentioned above, incubation for 1 h at room temperature was performed with 
the secondary, horse-radish peroxidase conjugated rabbit-anti-mouse IgG antibody, diluted 
1:500 in PBS-T containing 1% (w/v) skimmed milk powder and 1% (m/v) BSA. After washing 
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the membrane as mentioned above, immunodetection was performed using enhanced 
chemiluminescence reagent ECL (Amersham Biosciences, Buckinghamshire, UK) on a 
hyperfilm ECL with various light exposure times. Molecular weights were determined in 
comparison to a commercially available protein standard. 
 
Enzyme assays 
A standard incubation mix consistent of 100 mM (CYP1A2) or 200 mM (CYP3A4) potassium 
phosphate buffer (pH 7.4), a NADPH-regeneration system (2.6 mM NADP+, 6.6 mM MgCl2, 
6.6 mM glucose-6-phosphate, and 0.4 U/ml glucose-6-phosphate dehydrogenase) and the 
insect cell membrane fraction containing human CYP1A2 (0.5 pmol) or human CYP3A4 (1 
pmol) together with NADPH-CYP reductase and cytochrome B5 were used in a final volume of 
50 µl (Becton Dickinson Ltd., Allschwil Switzerland). For measurement of CYP1A2 
demethylation activity 100 µM luciferin 6’ methyl ether was used (Catalys Ltd. Wallisellen, 
Switzerland). For measurement of CYP3A4 debenzylation activity 50 µM luciferin 6’ benzyl 
ether was used (Catalys Ltd. Wallisellen, Switzerland). Incubations were performed at room 
temperature for 30 minutes. To stop the reaction 50 µl luciferin detection reagent (Catalys Ltd. 
Wallisellen, Switzerland) was added. Control reactions to exclude an interaction of GTE or 
EGCG with membrane proteins were performed by preincubation of the substance of interest 
with insect membranes not harbouring the respective CYP isoenzyme. After incubation at 
room temperature for 20 minutes the formation of the luminogenic metabolite was quantified 
by recording luminescence with a HTS 7000 Plus Bio Assay Reader (Perkin Elmer Ltd., 
Buckinghamshire, UK). 
 
Data analysis 
For statistical comparison, data of groups were compared by analysis of variance (ANOVA). 
The level of significance was P ≤ 0.05. If this analysis revealed significant differences, pairwise 
comparisons within groups were performed by two-sided unpaired t-tests. P-values were 
adjusted by Bonferroni's correction for multiple comparisons. 
 
 
4.4 Results 
Colorimetric cytotoxicity assays were performed to determine the non-toxic range of GTE and 
EGCG in LS-180 or Caco-2 cells. Figure 4.1 shows that concentrations of GTE ≤0.4 mg/ml or 
EGCG ≤200 µM did neither exert dramatic toxic effects in LS-180 cells nor in Caco-2 cells. 
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Figure 4.1: Dose-dependent toxicity of GTE and EGCG in LS-180 cells or Caco-2 cells over 72h using the 
sulforhodamine B assay. Data represents the mean values (±SEM) of 3 experiments. LS-180 cells: (*) statistically 
significant different from control values of (p<0.005); Caco-2 cells: (**) statistically significant different from control 
values (p<0.0001). 
 
Quantitative real-time PCR was used to monitor mRNA expression of the different CYP 
isoforms. The average Ct values of the different cytochromes were 28.5 (CYP1A1), 34.0 
(CYP1A2), and 35.4 (CYP3A4) in LS-180 cells and 27.9 (CYP1A1) and 33.8 (CYP1A2) in 
Caco-2 cells. For each single experiment, a standard curve was generated. Linearity was 
assumed, when the coefficient of correlation was greater than r = 0.9. 
In LS-180 cells CYP1A2 mRNA expression was significantly induced about 7-fold by GTE 
concentrations of 0.25 and 0.4 mg/ml, whereas 0.1 mg/ml GTE or EGCG did not modulate 
mRNA expression (Figure 4.2). Neither GTE nor EGCG did alter CYP1A1 mRNA expression. 
B[a]P showed a significant induction of CYP1A1 and CYP1A2 mRNA expression. Rifampicin 
significantly induced CYP3A4 mRNA expression, whereas none of the GTE or EGCG 
concentrations did alter CYP3A4 mRNA levels. 
In Caco-2 cells, GTE significantly induced CYP1A1 and CYP1A2 mRNA expression in a 
concentration-dependent manner up to 25-fold and 6-fold, respectively (Figure 4.3). Only the 
highest concentration of 100 µM EGCG significantly increased mRNA expression of CYP1A1 
about 5-fold and CYP1A2 mRNA expression about 3-fold. B[a]P significantly increased 
CYP1A1 and CYP1A2 mRNA expression.  The effect of B[a]P on mRNA levels of CYP1A1 
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was not modulated by coincubation with GTE or EGCG. Induction of CYP1A2 mRNA 
expression by B[a]P was significantly inhibited by 100 µM EGCG, whereas GTE or 4.02 to 
40.2 µM EGCG had no effect (Figure 4.4). Due to the low levels of CYP3A4 mRNA expression 
in Caco-2 cells (Pfrunder et al., 2003) the possible influence on CYP3A4 mRNA expression by 
GTE was not investigated in this cell line. 
 
 
 
Figure 4.2: Relative mRNA expression of (a) CYP1A1, (b) CYP1A2 and (c) CYP3A4 in LS-180 cells. 
Transcriptional expression was determined by quantitative real-time PCR. Cells were treated for 72h with medium 
only, or with either 10 µM rifampicin or B[a]P, or with different concentrations of GTE or EGCG. mRNA expression 
was relative to the respective control. Data represents the pooled results of 3 separate experiments (n=3). (* 
statistically significant difference, p < 0.01). Data represent means ± SEM 
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Figure 4.3: Relative mRNA expression of (a) CYP1A1 and (b) CYP1A2 in Caco-2 cells. Transcriptional expression 
was determined by quantitative real-time PCR. Cells were treated for 24h with medium only, or with either 10 µM 
B[a]P, or with different concentrations of GTE or EGCG. mRNA expression was relative to the respective control. 
Data represents the pooled results of 3 separate experiments (n=3). (* statistically significant difference, p < 0.05). 
Data represent means ± SEM 
 
 
Figure 4.4: Relative mRNA expression of (a) CYP1A1 and (b) CYP1A2. Transcriptional expression was determined 
in Caco-2 cells by quantitative real-time PCR. Cells were treated for 24h with 10 µM B[a]P and with different 
concentrations of GTE or EGCG. mRNA expression was relative to the respective expression induced by B[a]P. 
Data represents the pooled results of 3 separate experiments (n=3). (* statistically significant difference, p<0.05). 
Data represent means ± SEM 
 
 
Western blot analysis of total protein content from LS-180 or Caco-2 cells was performed to 
qualitatively determine whether the results of CYP1A1 and CYP1A2 mRNA expression 
experiments correlate with the respective levels of protein. Two major immunoreactive bands 
appeared (Figure 4.5), which are in accordance to literature data (Yang and Raner, 2005), 
indicated a cross-reactivity of the CYP1A2-antibody against CYP1A1. At confluence, LS-180 
cells or Caco-2 cells were incubated with or without 10 µM B[a]P or 0.4 mg/ml GTE for 72h or 
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24h, respectively. Western blot results were analogue to mRNA induction experiments. Only 
CYP1A2 protein detected in LS-180 cells did not correlate to the observed mRNA induction by 
B[a]P and GTE. 
 
 
 
Figure 4.5: Western blot analysis of CYP1A1 (58.3 kDa) and CYP1A2 (58.2 kDa) expression in (a) LS-180 cells 
and (b) Caco-2 cells. Two bands are shown corresponding to CYP1A2 (upper band) and CYP1A1 (lower band). 
Total cell protein, preincubated for 24h with or without 10 µM B[a]P or 0.4 mg/ml GTE, was electrophoretically  
separated and examined by western blotting with anti-CYP1A2 antibody at 1:1000 dilution. Protein from LS-180 
cells was applied at 150 µg in each lane, protein from Caco-2 cells was applied at 100 µg in each lane. 
 
 
The effect of 0.01, 0.1, or 1 mg/ml GTE, or corresponding EGCG concentrations on CYP1A2 
function was investigated (Figure 4.6a). GTE dose-dependently inhibited CYP1A2 activity. A 
reduction of activity of about 50% was observed for 0.1 mg/ml GTE and 402 µM EGCG. The 
highest concentration of GTE inhibited CYP1A2 activity at a similar extent as 100 µM 
furafylline. The influence of different GTE (0.01, 0.025, 0.05, 0.1, or 1 mg/ml) or EGCG (4.02, 
40.2, 402 µM) concentrations on CYP3A4 activity was examined (Figure 4.6b). GTE and 
EGCG significantly inhibited CYP3A4 activity in a dose-dependent manner. The extent of 
inhibition was similar or higher than the inhibition found for 2.5 µM ketoconazole (KTZ). 
 
 
Figure 4.6: Dose-dependent functional inhibition of CYP1A2 and CYP3A4 by GTE or EGCG. (a) Luciferin 6’ methyl 
ether (100 µM) was incubated with 0.5 pmol of human CYP1A2;  (b) luciferin 6’ benzyl ether (50 µM) was incubated 
with 1 pmol of human CYP3A4. Assays were performed at room temperature for 30 minutes. Insect cell membrane 
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harbouring each form of human CYP together with NADPH-CYP reductase and cytochrome B5 were used as 
enzyme sources. The luminogenic metabolite was quantified by recording luminescence. Data represents the 
pooled results of 3 separate experiments (n=3). (* statistically significant difference, p<0.05). Data represent means 
± SEM 
 
 
4.5 Discussion 
Small intestinal CYP metabolism has the potential to substantially affect the toxicity and 
therapeutic efficacy of orally administered xenobiotics by limiting systemic uptake (Watkins, 
1997). Therefore, our results might be of interest considering dietary interactions with medical 
therapies. However, in this study we showed that the mRNA expression patterns of CYP1A1 
and CYP3A4 in LS-180 cells were neither altered by GTE up to a concentration of 0.4 mg/ml 
nor by EGCG up to 100 µM. In contrast, GTE significantly induced CYP1A2 mRNA expression 
up to 7-fold in LS-180 cells at concentrations above 0.25 mg/ml. Interestingly, in Caco-2 cells 
GTE significantly increased mRNA expression of CYP1A1 as well as of CYP1A2 in a 
concentration-dependent manner. Similar effects have been shown recently in human liver and 
tongue cells (Allen et al., 2001; Yang and Raner, 2005). In Caco-2 cells EGCG induced 
CYP1A1 and CYP1A2 mRNA expression at a concentration of 100 µM, although less 
extensive than GTE. Importantly, it has to be considered that even the highest GTE 
concentration exhibited about 5-fold less inductive potential on CYP1A mRNA expression than 
B[a]P. 
Recently, it has been reported that GTE-mediated induction of CYP1A1 mRNA expression in 
the human hepatocyte derived cell line HepG2 is regulated via the aryl hydrocarbon receptor 
(AhR) pathway (Williams et al., 2000; Whitlock Jr., 1999). In this study significant B[a]P-
mediated induction of CYP1A1 mRNA expression was detected in both cell lines whereas GTE 
induced CYP1A1 mRNA only in Caco-2 cells. This suggests that there might be differences 
between Caco-2 and LS-180 cells concerning regulatory proteins involved in the induction of 
CYP1A1 by GTE. This is in accordance to our observation that Caco-2 cells differ from LS-180 
cells concerning the inductive potential of B[a]P. In LS-180 cells B[a]P induced mRNA 
expression of both CYP1A isoenzymes at a similar level. In Caco-2 cells, CYP1A2 mRNA 
expression was about 5-fold less induced by B[a]P than CYP1A1 mRNA expression, which 
ranged in a similar extent as in LS-180 cells. Interestingly, this feature was also found for the 
induction of CYP1A1 and CYP1A2 mRNA expression by GTE. A possible explanation for 
these differences might be that Caco-2 cells rather display similarities to human jejunal tissue, 
whereas LS-180 cells have retained their colonic characteristics (Taipalensuu et al., 2001; 
Pfrunder et al., 2003). We suggest that xenobiotic inducers of CYP1A increase CYP1A1 
expression more pronounced than CYP1A2 expression in human cells displaying jejunal 
characteristics. This is supported by a report where ingestion of omeprazole induced 
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predominantly CYP1A1 mRNA expression in the duodenum of healthy volunteers (McDonnell 
et al., 1992). Additionally, our results indicate that the induction of CYP1A mRNA expression 
by GTE cannot be reduced to the activity of EGCG, as EGCG alone was less effective than 
GTE. This is consistent to in vivo results, where the induction of CYP1A2 by green tea in the 
rat was ascribed to its caffeine content (Chen et al., 1996). 
When Caco-2 cells incubated with B[a]P were coincubated with GTE no change in CYP1A1 or 
CYP1A2 mRNA expression could be observed. This is partly in contrast to results where GTE 
inhibited 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated CYP1A1 and CYP1A2 mRNA 
accumulation in HepG2 cells, probably via AhR-agonist activities (Williams et al., 2000; 
Whitlock Jr., 1999; Williams et al., 2003). Partly in accordance with this study were our results 
that 100µM EGCG inhibited B[a]P-induced CYP1A1 mRNA expression, although not 
significantly, and CYP1A2 mRNA expression. As mentioned above differences of regulatory 
proteins involved in the induction of CYP1A1 by GTE in Caco-2 might be responsible for this 
observation. 
Results from the literature remain inconclusive regarding effects of green tea on CYP1A and 
CYP3A4 activities. Stimulatory as well as inhibitory activities in different in vivo or in vitro 
models have been described (Maliakal et al., 2001; Nishikawa et al., 2004; Yang and Raner, 
2005). To overcome autofluorescent and quenching activities of GTE observed before 
(Chapter 3.1), we used luminogenic substrates for measurement of CYP1A2 or CYP3A4 
activities. In accordance with the literature, we could detect a strong inhibitory effect at higher 
concentrations of GTE on CYP1A2 as well as on CYP3A4 function. This shows the non-
specific inhibitory activity of GTE against human CYP isoforms. As EGCG alone exerted only 
half of the inhibitory activities in concentrations corresponding to GTE containing the same 
amount of EGCG, other components in GTE may contribute to this effect. One possible 
candidate represents the CYP1A2 substrate caffeine. These effects were concentration 
dependent. Low concentrations of GTE did not significantly change CYP1A2 or CYP3A4 
activities. This was in accordance to an in vivo-study where CYP3A4 activity was not 
modulated after ingestion of GTE (Donovan et al., 2004). 
In summary, our findings demonstrate that GTE, although in a moderate manner in 
comparison to B[a]P, differentially induces CYP1A expression at the mRNA and protein level 
in the intestinal cell lines LS-180 and Caco-2. Whereas in LS-180 cells GTE induced only 
CYP1A2 expression, in Caco-2 cells GTE increased both CYP1A1 and CYP1A2 expression. 
These effects could not be reduced to the green tea component EGCG. Therefore, it appears 
that green tea moderately modulates the expression of drug-metabolising enzymes. A 
significant inhibition of CYP1A2 and CYP3A4 activity by GTE or EGCG at higher 
concentrations was demonstrated. This inhibitory activity might reflect the chemopreventive 
character of GTE. Cell-specific differences in the extent of induction of the expression of the 
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single CYP1A enzymes were observed, which we suggest to be related to tissue 
characteristics of the cell lines LS-180 and Caco-2. This might be of interest in the assessment 
of appropriate cell models for investigations on gastrointestinal drug metabolism. 
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5. Effect of green tea extract on tightness of intestinal 
epithelia 
 
 
5.1 Introduction 
Green tea is one of the most consumed beverages worldwide. Recent insights into 
beneficial/protective effects on life-style related diseases have rendered green tea 
preparations attractive for medicinal applications (Fujiki, 1999; Klaunig et al., 1999; Haqqi et 
al., 1999). Concerning possible modification of passive drug absorption, the purpose of this 
study was to clarify the influence of a green tea extract (GTE) and the green tea component (-
)-epigallocatechin gallate (EGCG) on the intestinal epithelial barrier function. Under normal 
conditions, the intestinal epithelium serves as a highly selective barrier that permits absorption 
of water, electrolytes, and various nutrients from the lumen while simultaneously restricting the 
passage of larger, potentially toxic compounds of microbial origin (Madara and Stafford, 1989). 
Increased permeability of this barrier has been implicated in the pathogenesis of several 
gastrointestinal disorders including inflammatory bowel disease (Farhadi et al., 2003). 
In a model for murine colitis protective effects of green tea have been demonstrated recently 
(Varilek et al., 2001). As EGCG has been shown to prevent the increase of epithelial 
permeability induced by interferon-γ (IFNγ) we hypothesised a similar effect of GTE on 
intestinal epithelial cells (Watson et al., 2004). 
To assess the effect of GTE and EGCG, after preincubation for 72 hours, on the intestinal 
permeability we measured the apical to basolateral transport of [3H]sucrose or [14C]sucrose 
through Caco-2 monolayers over 5 hours. Caco-2 monolayers, which reflect many of the 
features of normal human small intestinal absorptive epithelium, have been widely used for 
studies of intestinal permeability (Meunier et al., 1995). IFNγ was demonstrated to increase the 
permeability of monolayers of intestinal epithelial cells in previous studies (Adams et al., 1993; 
Madara and Stafford, 1989). Because IFNγ receptors have been shown to be located in the 
basolateral membrane of Caco-2 cells (Unno et al., 1995), IFNγ was applied to the basolateral 
compartment for 72 hours ahead of the transport experiments. To elucidate a possible 
inhibitory effect of GTE or EGCG on the IFNγ-induced hyperpermeability of Caco-2 
monolayers, coincubation of IFNγ in the basolateral compartment and GTE or EGCG in the 
apical or basolateral compartment prior to transport studies was performed. With respect to the 
physiological situation the transwell insert system seems a suitable model to mimic the 
separation of the intestinal lumen from the submucosa through the intestinal cell monolayer. 
 
 58
5.2 Materials and methods 
Chemicals: 
(-)-Epigallocatechin gallate (EGCG) was from CHEMOS GmbH, Regenstauf, Germany, human 
recombinant Interferon-γ (IFNγ) was from Sigma-Aldrich CO, St. Louis, MO, USA, [3H]sucrose 
and [14C]sucrose were from Amersham Pharmacia, UK. All other chemicals were obtained 
from commercial sources in the highest quality available. 
 
Materials: 
Standardized green tea special extract EFLA942 (GTE) was from Frutarom Switzerland Ltd., 
Wädenswil, Switzerland. A brief manufacturing description was given in Chapter 2.2. 
 
Cell culture 
Caco-2 cells from the American Tissue Culture Collection (ATCC, Manassas, USA) were 
cultured in Dulbecco’s MEM with Glutamax-I, supplemented with 10% (v/v) fetal calf serum 
(FCS), 1% non-essential amino acids, 1% sodium pyruvate, and 50 µg/ml gentamycin at 37°C 
in 5% CO2. Only freshly prepared and sterile filtered (0.2 µm) mixtures of GTE or EGCG with 
medium were used. All cells used in this study were between passages 40 and 68. 
 
Transport assay 
Confluent monolayers of Caco-2 cells, which were grown in 0.4 µm pore Transwell-Clear filter 
inserts (no. 3460, Corning Costar), were incubated for 72 hours at 37°C in the presence or 
absence of 0.01 mg/ml or 0.1 mg/ml GTE, or 4.02 µM or 100 µM EGCG in the apical 
compartment. Cell culture medium or 1000 U/ml IFNγ with or without 100 µM EGCG was 
applied to the basolateral compartment. Control monolayers were incubated with cell culture 
medium only. Medium was changed every day. Transport experiments were performed in 
HBSS (pH 7.4) containing 10 % sodium pyruvate in the presence of absence of the substance 
of interest. Cells were washed twice, followed by an incubation at 37°C in the presence of 0.3 
µCi [3H]sucrose in the apical compartment. After 5, 15, 25, 35, 45, 60, 90, 120, 150, 180, 210, 
240, and 300 minutes, 100µl samples were removed from the basolateral compartment. When 
cells were incubated at 37°C in the presence of 0.3 µCi [14C]sucrose, 100µl samples were 
removed from the basolateral compartment after 15, 30, 45, 60, 90, 120, 150, 180, 210, 240, 
300, and 360 minutes For the quantification of the [3H]sucrose or [14C]sucrose concentration 
the samples were transferred to a vial containing 3 ml of scintillation cocktail (Insta-Gel, 
Packard Instrument B.V., NL). Finally, radioactivity was measured. All data are expressed as 
means ± S.D. of quadruple experiments and each experiment was performed twice. 
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Cytotoxicity: 
Cytotoxicity of GTE and IFNγ was screened in Caco-2 cells at confluence. Cells were 
incubated for 72 hours in the absence or presence of 1-10’000 U/ml IFNγ, respectively. 
Replacement with medium containing the compound of interest was done every 24 h. Cultures 
fixed with trichloroacetic acid were stained for 30 minutes with 0.4% sulforhodamine B (SRB) 
dissolved in 1% acetic acid. Unbound dye was removed by washing four times with 1% acetic 
acid and protein bound dye was extracted with 10 mM Tris buffer. Absorption was measured at 
540 nm. (Spectra MAX 250, Microplate Spectrophotometer, Molecular Devices Corporation, 
California, USA) [12]. SRB absorption intensity correlates linearly with the number of vital cells. 
Every experiment was performed in quintuplicate and all experiments have been repeated at 
least twice. 
 
Statistics: 
For statistical comparison, data of groups were compared by analysis of variance (ANOVA). 
The level of significance was P ≤ 0.05. If this analysis revealed significant differences, pairwise 
comparisons within groups were performed by two-sided unpaired t-tests. P-values were 
adjusted by Bonferroni's correction for multiple comparisons. 
 
 
5.3 Results 
To exclude artefacts during transport experiments in respect of reduced cell viability, 
cytotoxicity of IFNγ or GTE on Caco-2 cells was determined preliminary. The tested IFNγ 
concentrations (1-10’000 U/ml) did not exert toxic effects on Caco-2 cells (data not shown). No 
dramatic toxic effects in Caco-2 cells were observed at concentrations of GTE ≤0.4 mg/ml (see 
chapter 4). 
The concentration of 0.01 or 0.1 mg/ml GTE, or 4.02 µM EGCG, was applied during the 
preincubation period of the transport studies and during transport assay. Control monolayers 
were incubated with medium only. In contrast to the effect of IFNγ, no significant modulation of 
[3H]sucrose transport through Caco-2 monolayers was found for GTE or EGCG (Figure 5.1). 
The significant increase of transcellular transport of [3H]sucrose induced by IFNγ in the 
basolateral compartment was not prevented by apical application of GTE or EGCG (Figure 
5.2). 
For transport studies with [14C]sucrose Caco-2 monolayers were preincubated with or without 
IFNγ in the basolateral compartment and with or without 100 µM EGCG in the apical or 
basolateral compartment. Control monolayers were incubated with medium only. IFNγ 
significantly increased transcellular permeability of [14C]sucrose, whereas EGCG decreased 
transcellular permeability no matter if added to the apical (Figure 5.3) or basolateral (Figure 
 60
5.4) compartment. EGCG did abrogate the IFNγ-mediated effect when coincubated with IFNγ. 
In contrast to the logarithmic curve obtained for [3H]sucrose, the curve observed with 
[14C]sucrose showed an exponential growth (Figure 5.3). 
 
 
5.4 Discussion 
Various epithelial functions are directly modulated by cytokines like IFNγ as described in 
several in vitro studies (Madara and Stafford, 1989; McKay and Baird, 1999). Green tea has 
been shown to inhibit activation of IFNγ-induced signal transduction (Menegazzi et al., 2001; 
Watson et al., 2004). Increased epithelial permeability and a concomitant increase in tissue 
levels of cytokines including IFNγ is common in inflammatory enteropathies (Desreumaux et 
al., 1997; Inoue et al., 1999). Therefore, strategies to prevent this cytokine-mediated 
hyperpermeability would be of therapeutic benefit. 
 
 
Figure 5.1: Time-dependent apical to basolateral transport of [3H]sucrose after incubation with or without 
IFNγ basolaterally, or GTE or EGCG apically for 72 h. 
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Figure 5.2: Time-dependent apical to basolateral transport of [3H]sucrose after co-incubation of IFNγ basolaterally 
and GTE or EGCG apically for 72 h. 
 
Figure 5.3: Time-dependent apical to basolateral transport of [14C]sucrose after incubation with or without IFNγ 
and/or 100 µM EGCG for 72 h. 
 62
 
Figure 5.4: Time-dependent apical to basolateral transport of [14C]sucrose after incubation with or without IFNγ 
and/or 100 µM EGCG for 72 h. 
 
 
In our study using Caco-2 cells, 100 µM EGCG was shown to inhibit apical to basolateral 
[14C]sucrose transport no matter if applied apical or basolateral. IFNγ-induced 
hyperpermeability was blocked by EGCG as described for T84 cells (Watson et al., 2004). 
Interestingly, while apical applied EGCG only reduced IFNγ-mediated leakiness to basal 
levels, basolateral co-incubation of EGCG along with IFNγ showed a decreased permeability 
as observed for EGCG alone. This discrepancy might be due to an apical efflux of EGCG 
mediated by MRP2 or P-gp as described in the literature (Hong et al., 2002; Jodoin et al., 
2002). At lower concentrations, neither EGCG nor GTE did modulate basal or INFγ-mediated 
hyperpermeability when [3H]sucrose was used as substrate. Remarkably, it has to be noted 
that the two substrates, [14C]sucrose and [3H]sucrose, showed different permeability 
characteristics through the Caco-2 cell monolayer. As this is not related to the sucrose 
molecule itself, we suggest as cause a decomposition of sucrose-bound tritium with protons of 
H2O in the storage solution. The increase in the rate of decomposition during storage is 
characteristic of many tritium labelled compounds. As expected, a rapidly increasing 
radioactivity towards a limit of equal distribution was observed. However, this demonstrates 
the passive diffusion of water from the medium through the Caco-2 cell monolayer. In 
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accordance to the literature, in all experiments the overall penetration rate was very low, with 
about 1% of total tracer after 5 h of incubation (Watson et al., 2004). 
In summary, higher EGCG concentrations reduced basal and IFNγ-induced hyperpermeability 
of Caco-2 cell monolayers. Nevertheless, regarding the low penetration rate of the marker 
substrate we suggest that this effect may not be of relevance in vivo. Therefore, these results 
suggest that ingestion of green tea or GTE does not influence absorption of low molecular 
weight constituents in the intestine. 
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6. Side project: Influence of green tea extract on intestinal 
cytokine expression and secretion 
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6.1.1 Abstract 
The chemokine interleukin (IL)-8 is a cytokine involved in neutrophil attraction and activation 
and elevated levels have been observed in intestinal inflammation. Anti-inflammatory activities 
have been attributed to green tea or its major constituent (-)-epigallocatechin gallate (EGCG). 
In this study, we investigated the effects of a defined green tea extract (1) or EGCG (2) on 
basal or IL-1β-induced IL-8 expression and secretion in the human gastrointestinal epithelial 
cell line Caco-2. mRNA expression levels were determined by quantitative RT-PCR. 1 and 2 
significantly induced IL-8 mRNA expression, which was not mediated indirectly via an 
induction of IL-1β mRNA expression. Intracellular and extracellular protein levels were 
analysed by enzyme-linked immunosorbent assay. 1 and 2 significantly decreased secreted 
IL-8 concentrations. Determination of intracellular and secreted IL-8 concentrations after 24 h, 
48 h, and 72 h of incubation suggested that 1 specifically inhibited IL-8 secretion while 
inducing new synthesis of IL-8. IL-1β-mediated increase of IL-8 secretion was significantly 
inhibited by 1 in a dose-dependent manner. At highest concentration, 1 inhibited IL-1β-induced 
IL-8 secretion in a similar extent as found for brefeldin A, a fungal inhibitor of vesicular 
transport. These results suggest that 1 may exert an anti-inflammatory activity in enterocytes, 
which may be useful for the treatment of intestinal inflammation. 
 
 
6.1.2 Introduction 
Intestinal epithelial cells play an important role in the enteric immune system. This is achieved 
by forming a physical barrier against the microbial flora as well as by their ability to initiate a 
transient inflammatory response (Yang et al., 1997). Accordingly, intestinal epithelial cells 
secrete a wide array of inflammatory mediators such as cytokines, e.g. IL-1β, and chemokines, 
e.g. IL-8, that are able to induce an inflammatory state in intestinal cells or to attract 
inflammatory immune cells (Yang et al., 1997; Woywodt et al., 1994). An increase in the 
number and activity of inflammatory cells in the gut mucosa contributes, by their physical 
presence and secreted products, to the inflammation associated tissue damage and 
ulceration. Accordingly, intestinal inflammatory response needs to be tightly regulated as 
dysregulation of inflammation has been observed in inflammatory bowel diseases (IBD) 
including Crohn’s disease and ulcerative colitis (Papadakis and Targan, 2000). This has been 
demonstrated by several studies where elevated levels of inflammatory chemokines such as 
interleukin (IL)-8 in intestinal tissues of IBD patients have been described (MacDermott et al., 
1998; Puleston et al., 2005). IL-8 is a member of the CXC family of chemokines and plays a 
critical role in neutrophil recruitment and activation (Baggiolini et al., 1994; Baggiolini, 1998). 
IL-8 can be produced by different cell types, including the human gastrointestinal epithelial cell 
line Caco-2, and has been implicated in the initiation and maintenance of the inflammatory 
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response (Harada et al., 1994; Eckmann et al., 1993). Furthermore, the proinflammatory 
cytokine IL-1β represents a pivotal player in the intestinal inflammatory response (Ligumsky et 
al., 1990). Its significance in IBD has been demonstrated by the increased expression in 
affected tissues and the attenuation of its damaging properties by the IL-1 receptor antagonist 
(Cominelli et al., 1992; Casini-Raggi et al., 1995). Accordingly, the maintenance of a normal 
mucosal steady state is dependent on mechanisms that control the tissue concentrations of 
inflammatory chemokines and cytokines. The extracellular concentration of these inflammatory 
mediators can be, at least in part, regulated on two levels in the cell, the new synthesis of the 
mediators as well as the secretion of newly synthesized mediators. 
The physiological close proximity of luminal nutrients to intestinal cells may favour the 
influence of these nutrients on biological processes within the intestinal mucosa. Natural 
compounds including green tea [dried leaves of the plant Camellia sinensis (L.) O. KUNTZE 
(Theaceae)] have been shown to modulate inflammation in vitro and in vivo (Chen et al., 2003; 
Varilek et al., 2001). Recently, inhibitory effects of green tea polyphenols on IL-8 expression 
and secretion have been reported in intestinal epithelial cells, respiratory epithelial cells, 
endothelial cells, and keratinocytes (Porath et al., 2005; Chen et al., 2002; Tang and Meydani, 
2001; Trompezinski et al., 2003). 
In the present study we examine whether a defined commercially available green tea extract 
(1), or its main constituent EGCG (2), are capable to modulate basal or IL-1β-induced mRNA 
expression of the chemokine IL-8 in the human colonic adenocarcinoma cell line Caco-2. 
Furthermore, we assessed the effect of 1 and 2 on the secretion of IL-8 protein in Caco-2 cells. 
Due to the inhibition of IL-8 secretion by 1 we investigated the time-dependent effect of 1 on 
the concentration of newly synthesized IL-8 protein in the cell and the extracellular 
concentration of secreted IL-8. Finally, we evaluated the influence of 1 on IL-1β-induced IL-8 
mRNA expression and IL-8 protein secretion in Caco-2 cells. The observed inhibition of IL-1β-
induced IL-8 secretion was compared with the effect of a strong inhibitor of secretion, the 
fungal derivative brefeldin A (BFA). 
 
 
6.1.3 Results and discussion 
Effect of GTE (1) or EGCG (2) on basal or IL-1β-induced IL-8 mRNA expression in Caco-
2 cells. As shown in Figure 6.1, IL-8 mRNA expression was significantly induced by 1 in a 
dose-dependent manner up to 6-fold after an incubation period of 24 h. A significant increase 
in IL-8 mRNA expression (about 2-fold) occurred with 2 only at the highest concentration. This 
was in contrast to a recently reported EGCG-mediated reduction of IL-8 mRNA levels in two 
intestinal cell lines, HT-29 and T84 (Porath et al., 2005). In accordance to the literature, the 
positive control IL-1β showed a significant induction of IL-8 mRNA expression (Haller et al., 
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2000). The induction of IL-8 mRNA expression by IL-1β was in the same magnitude as found 
for the highest concentration of 1. 
 
 
Figure 6.1: Effect of compound 1 or 2 on IL-8 mRNA expression in Caco-2 cells after incubation for 24 h. 
Transcriptional expression was determined by quantitative real-time PCR. Each data value is expressed as a 
percentage of the control. Data represent the pooled results of 3 separate experiments (n=3) and the bars represent 
means ± SEM. An asterisk (*) indicates p < 0.05 when compared to the control. 
 
 
Figure 6.2: Effect of compound 1 on TNF-α mRNA expression in Caco-2 cells. Transcriptional expression was 
determined by quantitative real-time PCR. Compound treatment time and data presentation are the same as 
described in Figure 6.1. 
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In a next step the induction of tumour necrosis factor (TNF)-α mRNA expression was 
investigated. A significantly induction of TNF-α mRNA expression was observed for the 
positive control IL-1β (about 7-fold), which has been reported before, while only the highest 
concentration of 1 significantly induced TNF-α mRNA expression about 3-fold (Figure 6.2) 
(Vallee et al., 2004). TNF-α mRNA expression levels were not significantly altered by 2 up to 
100 µM (data not shown). 
To exclude that the observed induction of IL-8 and TNF-α mRNA expression by 1 is mediated 
by an induction of IL-1β expression, the influence of 1 on IL-1β mRNA expression levels were 
determined. While 1 did not alter IL-1β mRNA expression levels, IL-1β significantly induced its 
own mRNA expression (about 2-fold) as described in the literature (data not shown) (Jobin et 
al., 1997). Besides, under the same experimental conditions 2 also did not change IL-1β 
mRNA levels (data not shown). 
The stability of IL-8 mRNA has been described to be dependent on the presence of IL-1β in 
fibroblast cells (Stoeckle, 1990). By measurement of the effect of 1 on IL-8 mRNA stability we 
wanted to assessed if 1 post-transcriptionally regulates IL-8 mRNA in Caco-2 cells. Therefore, 
cells were incubated with 0.4 mg/ml of 1 for 24 h in order to obtain an induction of IL-8 mRNA 
expression. In a next step transcription was blocked with actinomycin D and the effect of 1 on 
the amount of IL-8 mRNA was detected after 7 h by quantitative real-time PCR. Our results 
showed that 1 does not significantly modulate IL-8 mRNA decay in Caco-2 cells (data not 
shown). Therefore, the observed induction of IL-8 mRNA expression by 1 was not related to an 
increase of IL-8 mRNA stability by 1. 
 
 
Figure 6.3: Effect of compound 1 or 2 on IL-8 protein secretion in Caco-2 cells after incubation for 24 h. IL-8 
concentrations in the supernatants were determined by EIA. Data represent the pooled results of 3 separate 
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experiments (n=3) and the bars represent means ± SEM. An asterisk (*) indicates p < 0.05 when compared to the 
control. 
 
 
Effect of GTE (1) on de novo synthesis and secretion of IL-8 in Caco-2 cells. Secreted IL-
8 protein levels were significantly reduced by 1 at 0.25 mg/ml and 0.4 mg/ml after an 
incubation of 24 h as determined by enzyme-linked immunosorbent assay (EIA) (Figure 6.3). 
Basal concentrations of secreted IL-8 protein were about 40 pg/ml, which was significantly 
reduced by 1 to about 15 pg/ml. At highest concentration, 2 also reduced secreted IL-8 
concentration, although to a lower extend than 1. The positive control IL-1β significantly 
increased secreted IL-8 concentration to about 320 pg/ml, which is probably due to the 
observed induction of IL-8 mRNA expression. Therefore, the overall effect of 1 on basal IL-8 
secretion seems to be of temperate manner in Caco-2 cells. 
 
 
Figure 6.4: Time-dependent effect of compound 1 on intracellular and secreted IL-8 protein concentration in Caco-
2 cells. Medium with or without the substance of interest was changed every 24 h. IL-8 concentrations in the (a) cell 
lysates or the (b) supernatants were determined by EIA. Data represents the pooled results of 3 separate 
experiments (n=3). Data presentations are the same as described in Figure 6.3. 
 
 
As this inhibition of IL-8 protein secretion by 1 was in contrast to the observed induction of IL-8 
mRNA expression, we wanted to clarify the effect of 1 on the IL-8 protein expression and the 
IL-8 protein secretion in Caco-2 cells. We therefore assessed the time-dependent effect of 1 
on the intracellular and extracellular IL-8 concentration over a time period of 72 h. At highest 
concentration, 1 significantly increased intracellular IL-8 protein concentration after 48 h of 
incubation in Caco-2 cells (Figure 6.4a). This confirms the induction of IL-8 mRNA expression 
by 1 at the protein level and suggests a time lag of 24 h to 48 h between induction of 
transcription and resulting translation into protein. The significant inhibition of IL-8 protein 
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secretion by 1 was constant over 72 h (Figure 6.4b). However, incubations with IL-1β 
demonstrated that the increase of secreted IL-8 protein concentration after an incubation 
period of 24 h was related to an early phase induction of IL-8 expression. After a first increase, 
we found a significant time-dependent decrease of IL-8 protein expression during incubation 
with IL-1β, which accordingly resulted in decreased levels of secreted IL-8. The time-
dependent down-regulation of IL-1β-mediated IL-8 expression has to be confirmed at the 
mRNA level. This desensitisation of IL-8 expression to IL-1β may be explained by an IL-1β-
mediated induction of IL-1 receptor antagonist expression, which inhibit IL-1β-induced IL-8 
production in Caco-2 cells as reported in the literature (Bocker et al., 1998; Garat and Arend, 
2003). 
To assess the specificity of the inhibition of IL-8 secretion by 1, we additionally investigated the 
effect of 1 on secreted TNF-α protein levels in Caco-2 after an incubation time of 24 h (data 
not shown). According to the results from the mRNA induction experiments, 1, at the highest 
concentration of 0.4 mg/ml, significantly increased secreted IL-8 protein concentrations about 
2-fold and seems not to inhibit secretion. Therefore we suggest that 1 inhibits the secretion of 
IL-8 in Caco-2 cells specifically. However, it has to be noted that basal levels of secreted TNF-
α protein were already relatively high (about 2 pg/ml). Therefore, the small increase from 2 
pg/ml to 4 pg/ml mediated by 1 might not account for a proinflammatory activity of 1 via TNF-α 
induction (Komatsu et al., 2001). 
Effect of GTE (1) on IL-1β-induced expression and secretion of IL-8 in Caco-2 cells. 
Finally, we wanted to investigate the effect of 1 on IL-1β-induced IL-8 secretion in Caco-2 
cells. After a preincubation of the cells with IL-1β for 1 h, 1 was added to the medium for 23 h. 
We observed a significant decrease of IL-1β-induced extracellular IL-8 protein levels by 1 in a 
concentration-dependent manner (Figure 6.5). Similar results were obtained when IL-1β was 
co-incubated with 1 for 24 h without a preincubation phase (data not shown). As 1 did not 
significantly alter IL-1β-induced IL-8 mRNA expression (data not shown) or IL-1β-induced 
intracellular IL-8 protein concentration (Figure 6.6) after an incubation of 24 h, evidence is 
given that 1 inhibits the secretion of IL-1β-induced newly synthesized IL-8 protein. To estimate 
the strength of inhibition of IL-8 secretion by 1, we compared the effects of 1, at the highest 
concentration of 0.4 mg/ml, and brefeldin A (BFA). The lipophilic fungal antibiotic BFA is a 
potent inhibitor of protein secretion, which it inhibits at an early step in the secretory pathway 
(Klausner et al., 1992).  1 and BFA significantly inhibited IL-8 secretion induced by IL-1β in a 
similar extent in Caco-2 cells (Figure 6.6). Noteworthy, BFA seemed to induce IL-8 expression 
in Caco-2 cells as intracellular IL-8 protein concentrations were significantly increased. 
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Figure 6.5: Concentration-dependent effect of compound 1 on IL-1β-induced IL-8 protein secretion in Caco-2 cells. 
Cells were pre-incubated at 37°C for 1 h with or without 10 ng/ml IL-1β. Subsequently, GTE was added to the 
medium followed by an incubation for 23 h. IL-8 concentrations in the supernatants were determined by EIA. Data 
represent the pooled results of 3 separate experiments (n=3) and the bars represent means ± SEM. An asterisk (*) 
indicates p < 0.05 when compared to IL-1β. 
 
 
 
Figure 6.6: Comparison of the effect of compound 1 or brefeldin A (BFA) on basal or IL-1β-induced IL-8 protein 
expression and secretion in Caco-2 cells after an incubation for 24 h. IL-8 concentrations in the cell lysates or 
supernatants were determined by EIA. Data represent the pooled results of 3 separate experiments (n=3) and the 
bars represent means ± SEM. An asterisk (*) indicates p < 0.05 when compared to the control, a cross (+) indicates 
p < 0.05 when compared to IL-1β. 
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While low plasma concentrations of green tea catechins have been reported, the 
gastrointestinal tract is likely to be exposed to higher concentrations of green tea constituents, 
irrespective of whether they are absorbed, retained, or recirculated to the gut tissues (Chow et 
al., 2001; Lee et al., 2002). This suggests that our results concerning the specific inhibition of 
IL-8 secretion found for 1 in the intestinal cell line Caco-2 might be of relevance in vivo. As 1 
also inhibited IL-8 secretion in enterocytes activated with IL-1β, evidence is given for a 
chemopreventive potential of 1. The production of chemokines, including IL-8, by epithelial 
cells and leukocytes establishes a chemotactic gradient within the intestine. This enables a 
migration of activated lymphocytes, macrophages, and granulocytes from the circulation into 
the mucosa as observed during intestinal inflammation (MacDermott, 1999). Therefore, the 
specific inhibition of IL-8 secretion by 1 in Caco-2 cells may be, at least in part, responsible for 
an anti-inflammatory activity of 1. An attenuation of intestinal inflammation after orally ingestion 
of green tea polyphenols has been reported recently in a murine model of IBD (Varilek et al., 
2001). Regarding the moderate effects of 2, it is tempting to speculate that other green tea 
components are responsible for the demonstrated inhibition of IL-8 secretion by 1. The results 
of this study may point to a beneficial effect of green tea in the prevention or treatment of 
intestinal inflammation. However, more preclinical and clinical studies are necessary to judge 
the relevance of our findings. 
 
 
6.1.4 Experimental section 
Experimental biologic materials: 
Standardized green tea special extract EFLA942 (1) was from Frutarom Switzerland Ltd., 
Wädenswil, Switzerland. Brief manufacturing description: leaves of Camellia sinensis (L.) O. 
KUNTZE are continuously extracted (percolation) with 80% (w w-1) ethanol. After a patented 
filtration process (US 6024998) the crude extract is dried. Finally, 5% w w-1 maltodextrin is 
added as carrier. The drug to extract ratio (DER) is 5.5=1. Characteristic components in the 
extract are polyphenols (47.5-52.5% w w-1), caffeine (5.0-10.0% w w-1), theobromine (0.30-
1.20% w w-1), and theanine (1.0-3.0% w w-1). 
 
Cell culture and general experimental procedures 
The human colon adenocarcinoma cell line Caco-2 was purchased from American Tissue 
Culture Collection (ATCC, Manassas, USA) and cultured in Dulbecco’s MEM (DMEM) with 
Glutamax-I, supplemented with 10% (v v-1) fetal calf serum (FCS), 1% non-essential amino 
acids, 1% sodium pyruvate and 50 µg/ml gentamycin. All cultures were maintained in a 
humidified 37°C incubator with 5% carbon dioxide in air atmosphere. All cells used in this 
study were between passages 40 and 68. EGCG (2) was from CHEMOS GmbH, Regenstauf, 
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Germany. IL-1β was from Becton Dickinson Ltd., Wallisellen, Switzerland. Actinomycin D and 
BFA were from Sigma, Switzerland. All other chemicals were obtained from commercial 
sources in the highest quality available. 
 
Real-time polymerase chain reaction (TaqMan assay): 
For mRNA induction experiments Caco-2 cells, at confluence, were incubated for 24 h with 
four different concentrations of 1 (0.01, 0.1, 0.25, or 0.4 mg/ml) or 2 (4.02, 40.2, 100, or 160 
µM) with or without 10 ng/ml IL-1β. Control cells were incubated for 24 h with medium only. In 
RNA stability experiments, cells were washed twice with phosphate-buffered saline (PBS) after 
induction with 0.4 mg/ml of compound 1 for 24h, and were then placed for 1 h or 8 h in serum-
free medium with or without 5 µg/ml ActD or 5 µg/ml ActD in combination with 0.4 mg/ml of 
compound 1. 
RNA extraction, reverse transcription, DNA digestion, and PCR amplification was performed 
as described before (Chapter 3.1.3). 
For IL-8 detection the following primers and probe (Acc.No. BT007067.1) were used: 5`-
CTTGGCAAAACTGCACCTTCACACAGA-3` (probe), 5`-CTCTTGGCAGCCTTCCTGATT-3` 
(forward), and 5`-TATGCACTGACATCTAAGTTCTTTAGCA-3` (reverse). For IL-1β detection 
the following primers and probe (Acc.No. NM_000576) were used: 5`-
TTCCAGGACCTGGACCTCTGCCCTC-3` (probe), 5`- CTGATGGCCCTAAACAGATGAAG -3` 
(forward), and 5`- GGTGGTCGGAGATTCGTAGC -3` (reverse). For TNF-α detection the 
following primers and probe (Acc.No. X02910) were used: 5`- 
TAGCCCATGTTGTAGCAAACCCTCAAGCT -3` (probe), 5`- TCTTCTCGAACCCCGAGTGA -
3` (forward), and 5`- CCTCTGATGGCACCACCAG -3` (reverse). 
A relative standard curve was generated by serial dilutions of cDNA. Fragments of cDNA 
corresponding to IL-8, IL-1β, or TNF-α that covered the TaqMan primer/probe area were 
obtained by PCR amplification. To standardize the amount of sample cDNA added to the 
reaction the calculated amount of the gene of interest was divided by the calculated amount of 
the constitutively expressed ribosomal 18S gene in the sample. These normalized amounts 
were then used to compare the relative amount of target in different samples. The expression 
level of the endogenous control gene 18S did not alter under any of the different treatments. 
The Ct values of the controls were 31.3, 33.2, and 28.2 for IL-8, TNF-α, and IL-1β, 
respectively. Standard curves of the respective mRNA were generated separately for each 
experiment and displayed linearity (R=0.9). 
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 Cytokine expression assays: 
To assess the effect on basal cytokine expression or secretion, Caco-2 cells, at confluence, 
were incubated for 24 h, 48 h, or 72 h with medium only, 10 ng/ml IL-1β, four different 
concentrations of 1 (0.01, 0.1, 0.25, or 0.4 mg/ml), or 2 (4.02, 40.2, 100, or 160 µM).  
To investigate the effect of compound 1 on IL-1β-induced IL-8 secretion, Caco-2 monolayers 
were preincubated with 10 ng/ml IL-1β for 1 h. Subsequently, cells were exposed to 10 ng/ml 
IL-1β with or without different concentrations of 1 (0.01, 0.1, 0.25, or 0.4 mg/ml) for 23 h. 
Control cells were incubated for 24 h with medium alone. 
To compare the effect on IL-8 secretion mediated by compound 1 with the effect of BFA on IL-
8 secretion, Caco-2 cells were incubated for 24 h with or without 0.4 mg/ml of 1, 5 µg/ml BFA, 
or 10 ng/ml IL-1β with or without 0.4 mg/ml of 1 or 5 µg/ml BFA. 
After incubation the supernatants were collected and, in some experiments, intracellular 
proteins were extracted by lysing a cell pellet in 1ml protein extraction buffer (pH 7.4), 
containing 20 mM Tris-HCl, 0.5 mM Na3VO4 and 1 % (v v-1) Igepal CA-630. Proteases were 
inhibited with 1mM PMSF, 8 µM leupeptin, 5 µM bestatin, 2 µg/ml aprotinin, 6 µM E-64 and 1 
µM pepstatin. IL-8 or TNF-α protein concentration was assayed using OptEIA enzyme-linked 
immunosorbent assay set (Becton Dickinson Ltd., Wallisellen, Switzerland) and detected using 
a HTS 7000 Plus Bio Assay Reader (Perkin Elmer Ltd., Buckinghamshire, UK). 
 
Statistical analysis: 
For statistical comparison, data of groups were compared by analysis of variance (ANOVA). 
The level of significance was P≤0.05. If this analysis revealed significant differences, pair wise 
comparisons within groups were performed by two-sided unpaired t-tests. P-values were 
adjusted by Bonferroni's correction for multiple comparisons. 
 
Acknowledgement 
We thank U. Behrens for excellent technical assistance. This work was supported by an 
unconditional research grant of Frutarom Switzerland Ltd., 8820 Waedenswil, Switzerland. 
 75
6.2 Evaluation of the effect of green tea extract on 
intracellular IL-8 protein stability 
 
 
6.2.1 Introduction 
Proteasome inhibitors have been shown to induce IL-8 mRNA expression and protein 
secretion in different human cell types including epithelial, endothelial, and monocytic cells 
(Hipp et al., 2002; Gerber et al., 2004). As green tea catechins were recently reported to inhibit 
proteasome activity in vitro as well as in tumour cells (Nam et al., 2001; Smith et al., 2004), we 
investigated the influence of GTE on intracellular IL-8 protein stability in Caco-2 cells. 
Assuming that GTE may also act as a proteasome inhibitor, the GTE-mediated induction of IL-
8 mRNA expression in Caco-2 cells described in Chapter 6.1 would be in accordance to the 
literature. In contrast to the proteasome inhibitors used in the literature such as lactacystin, 
GTE additionally exerted secretory inhibitor activity leading to increased intracellular IL-8 
protein concentrations (Chapter 6.1). 
For the assessment of the influence of GTE on IL-8 protein stability we used the classic pulse-
chase assay. In a first step, Caco-2 cells at confluence were starved with medium lacking 
cysteine. This leads to an attenuation of cellular protein synthesis as soon as the residing 
intracellular cysteine has been used up. Then the cells were incubated with medium containing 
radioactively labelled cysteine (pulse), which results in metabolically labelled proteins. Finally, 
the cells were incubated for different time periods with medium containing non-labelled 
cysteine with or without GTE (chase). After harvest, intracellular IL-8 proteins were 
immunoprecipitated from the cell lysates and analysed on SDS polyacrylamide gels by 
autoradiography. In comparison to Coomassie blue protein staining, the use of radioactive 
metabolic labelling has the advantage that after immunoprecipitation only IL-8 expressed 
during the defined pulse period is detected, which may be used for quantification of the results. 
An influence of GTE on intracellular IL-8 protein stability would result in quantitatively different 
radioactivity in comparison to the control. To balance the secretory inhibition described for 
GTE in Chapter 6.1, some control cells were additionally incubated during the chase with BFA, 
which inhibits the vesicular transport of the Golgi apparatus (Misumi et al., 1986). For control 
reasons, some cells were incubated with GTE and BFA simultaneously during chase. The 
inhibition of IL-8 secretion by BFA or GTE was confirmed by analysis of supernatants using 
EIA. 
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6.2.2 Materials and methods 
Materials and cell culture 
Caco-2 cells were seeded in 60 mm dishes and grown in DMEM with Glutamax-I, 
supplemented with 10% heat-inactivated FBS, 1% non-essential amino acids, 1% sodium 
pyruvate and 50 µg/ml gentamycin (chase medium). All cultures were maintained in a 
humidified 37°C incubator with 5% carbon dioxide in air atmosphere. Standardized green tea 
special extract EFLA942 (GTE) was from Frutarom Switzerland Ltd., Wädenswil, Switzerland. 
A brief manufacturing description was given in Chapter 2.2. [35S]-L-cysteine (370 MBq/ml, 10 
mCi/ml) was from Amersham Pharmacia, UK. N-ethylmaleimide (NEM) was from Sigma, 
Switzerland. 
 
Metabolic labelling 
After washing three times with prewarmed PBS cells at confluence were starved for 30 
minutes in DMEM with Glutamax-I lacking cysteine (GIBCO BRL Life Technologies), 
supplemented with 10% heat-inactivated FBS, 1% non-essential amino acids, 1% sodium 
pyruvate and 50 µg/ml gentamycin (starvation medium). The cells were then incubated in 
starvation medium containing [35S]-L-cysteine (0.5-5 µCi/well) (pulse medium) for 1 h followed 
by an incubation for 1 h or 6 h in chase medium. In some experiments 0.4 mg/ml GTE, 5 µg/ml 
BFA, or a combination of GTE and BFA was added to the chase medium. Then the reaction 
was stopped by adding 20 mM NEM in PBS to the cells. Supernatants were collected for the 
determination of IL-8 concentration. Then the cells were solubilised for 30 min on ice in buffer 
containing 20 mM Tris-HCl, 0.5 mM Na3VO4 and 1 % (v/v) Igepal CA-630. Proteases were 
inhibited with 1mM PMSF, 8 µM leupeptin, 5 µM bestatin, 2 µg/ml aprotinin, 6 µM E-64 and 1 
µM pepstatin. 
 
Immunoprecipitation 
Cell lysates were incubated at 4°C for 16-24 h with protein A-Sepharose plus rabbit anti-IL-8 
polyclonal antibody (Abcam Ltd., Cambridge, UK) or anti-IL-8 monoclonal capture antibody of 
OptEIA enzyme-linked immunosorbent assay set (Becton Dickinson Ltd., Wallisellen, 
Switzerland). After recovery by centrifugation, the protein A-Sepharose beads were washed 
two times with HBSS containing 0.25% (v/v) Igepal CA-630 and two times in HBSS only. 
Bound proteins were eluted by the addition of 3X Laemmli sample buffer and analysed on 15% 
SDS polyacrylamide gels under reducing conditions. The gels were vacuum dried with or 
without a prestaining with Coomassie blue followed by destaining in 10 % acetic acid, 40 % 
methanol. The dried gels were exposed to hyperfilm ECL with various light exposure times. 
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Determination of secreted IL-8 concentrations was described in Chapter 6.1.4. 
 
 
 
 
Figure 6.7:  Coomassie blue staining of intracellular IL-8 immunoprecipitated with rabbit anti-IL-8 polyclonal 
antibody. 
 
 
Figure 6.8:  Concentration of extracellular IL-8 concentration in the chase medium 1 or 6 h after pulse. This figure 
shows one experiment. 
 
 
6.2.3 Results and discussion 
Two independent pulse-chase experiments were performed, while the extracellular 
concentration of IL-8 was only determined once by EIA. All the results of the 
immunoprecipitation showed a band of about 14 kDa and a faint band of about 20 kDa after 
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Coomassie blue staining (Figure 6.7), whereas no radioactive signal could be detected (data 
not shown). Secretion of IL-8 was inhibited in a similar extent by GTE or BFA (Figure 6.8). 
The Coomassie blue staining indicates that immunoprecipitation of IL-8 was successful, 
although the faint band at about 20 kDa was not expected. As intracellular IL-8 still contains 
about 100 amino acids (Chapter 1.4.2) we expected a molecular weight of about 10-14 kDa. 
The significant inhibition of IL-8 secretion by BFA or GTE (Figure 6.8) was similar to results 
described in figure 6.6. The cells incubated with medium alone seem to contain less 
intracellular IL-8 protein than cells incubated with BFA (Figure 6.7). This is in accordance to 
the increase of intracellular IL-8 concentration induced by BFA shown in figure 6.6. Incubations 
for different time periods showed no visible alteration of the intracellular IL-8 protein content. 
However, radioactively labelled IL-8 could not be detected. Incubation with BFA showed that 
secretion of metabolically labelled IL-8 during incubation with or without GTE was not the 
reason for the observed loss of signal. An explanation might be that the intracellular pool of 
metabolically labelled IL-8 has been secreted concomitant to its generation during the pulse 
phase. To exclude this possibility further experiments with BFA already added to the pulse 
medium should be performed. 
Additionally, intracellular IL-8 protein degradation might be that fast that after 1 h pulse and 1 h 
chase the amount of non-degraded labelled IL-8 was below the detection limit. Another 
possibility is that an excess of non-labelled IL-8 generated during the chase phase might 
compete with radioactively labelled IL-8 for the binding to IL-8 antibody for 
immunoprecipitation. Finally, the applied amount of 0.5-5 µCi/well [35S]-L-cysteine might have 
been too low for a detectable specific incorporation into IL-8 protein. 
Taken together, the classical pulse-chase method for the determination of protein degradation 
needs further validation for an establishment in our laboratory. As no signal of radioactive 
labelled IL-8 could be detected, it was not possible to determine in this experimental series the 
influence of GTE on intracellular IL-8 protein stability in Caco-2 cells. 
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6.3 Evaluation of the influence of green tea extract on the 
mRNA expression of different proinflammatory mediators 
 
 
6.3.1 Introduction 
During intestinal inflammation an array of different proinflammatory mediators is produced 
including cytokines, prostaglandins, and leukotriens. The proinflammatory cytokine IL-6 has 
been implicated to play a role in several intestinal diseases like IBD and colorectal carcinoma 
(Brown et al., 2002; Csiszar et al., 2004). In the intestinal mucosa IL-6 may regulate 
immunoglobulin A production in Peyer’s patch B cells, thereby influencing intestinal immune 
function (Beagley et al., 1989). Additionally, evidence is given for a key role of IL-6 in the 
regulation of acute phase protein synthesis in enterocytes (Molmenti et al., 1993). 
Nevertheless, recent studies suggest that IL-6 may exert also anti-inflammatory effects beside 
its commonly considered proinflammatory activity (Xing et al., 1998). It has been shown that 
IL-1β upregulates IL-6 expression at the transcriptional level in the intestinal cell line Caco-2 
(Parikh et al., 1997). In the human colon, arachidonic acid is metabolised primarily by 
cyclooxygenase (COX) and arachidonate lipoxygenase (ALOX) to prostaglandins and 
leukotriens, respectively, which are involved in a variety of physiological and pathological 
processes in the immune response and in inflammation. Cyclooxygenases (COX) enzymes 
catalyse the generation of prostaglandins. The inducible COX isoform, COX-2, has been 
implicated in colon cancer development and other sites of inflammation like IBD (Eberhart et 
al., 1994; Hendel and Nielsen, 1997). Lipoxygenase-5 (ALOX) is a key enzyme in the 
generation of leukotriens. It has been shown to play an important role in colonic tumorigenesis 
and experimental colitis (Ye et al., 2004; Cuzzocrea et al., 2005). However, no change of 
ALOX mRNA expression in the colon of patients with active inflammatory bowel disease has 
been found (Hendel et al., 2002). Nevertheless, substances modulating the production of IL-6, 
prostaglandins, or leukotriens in enterocytes may have important clinical implications. 
Green tea is widely consumed and it has been used medicinally in China for 5000 years. It 
was suggested that green tea possess anti-inflammatory as well as anticarcinogenic properties 
(Katiyar and Mukhtar, 1996). Green tea polyphenols have been reported to inhibit COX- and 
ALOX-dependent metabolism of arachidonic acid in human colon mucosa and colon tumour 
tissues (Hong et al., 2001). In intestinal cell lines, e.g. Caco-2, EGCG was shown to down-
regulate COX-2 mRNA expression and prostaglandin production (Porath et al., 2005). A 
potential effect of green tea on intestinal IL-6 expression and secretion has not been 
investigated yet.  
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The important role of the ALOX and COX-2 in the metabolism of arachidonic acid makes these 
enzymes possible therapeutic targets in gut inflammatory conditions. A modulation of IL-6 
production, and therefore of the mucosal immune function, might also be relevant in the 
management of intestinal inflammation. Several evidences have shown the benefits of green 
tea in a variety of inflammatory conditions (Hussain et al., 2005; Wheeler et al., 2004). Hence, 
we investigated the effect of different concentrations of GTE or its constituent EGCG on basal 
mRNA expression of IL-6, COX-2, and ALOX in Caco-2 cells. Additionally, the effect of GTE or 
EGCG on the influence of IL-1β on mRNA expression of these inflammatory mediators was 
investigated. 
 
 
6.3.2 Materials and methods 
Materials 
Standardized green tea special extract EFLA942 (GTE) was from Frutarom Switzerland Ltd., 
Wädenswil, Switzerland. A brief manufacturing description was given in Chapter 2.2. (-)-
Epigallocatechin gallate (EGCG) was from CHEMOS GmbH, Regenstauf, Germany. IL-1β was 
from Becton Dickinson Ltd., Wallisellen, Switzerland. All other chemicals were obtained from 
commercial sources in the highest quality available. 
 
Cell culture was described in Chapter 5.2. 
 
Real-time polymerase chain reaction (TaqMan assay) 
For mRNA induction experiments Caco-2 cells, at confluence, were incubated for 24 h with 
four different GTE concentrations (0.01, 0.1, 0.25, or 0.4 mg/ml) or EGCG concentrations 
(4.02, 40.2, 100 µM) with or without 10 ng/ml IL-1β. Control cells were incubated for 24 h with 
medium only. RNA extraction, reverse transcription, DNA digestion, and PCR amplification 
was performed as described elsewhere (Chapter 3.1.3). 
For IL-6 detection the following primers and probe (Acc.No. M54894.1) were used: 5`- 
TTACTCTTGTTACATGTCTCCTTTCTCAGGGCTG -3` (probe), 5`- 
TGACAAACAAATTCGGTACATCCT-3` (forward), and 5`- AGTGCCTCTTTGCTGCTTTCAC -
3` (reverse). For COX-2 detection the following primers and probe (Acc.No. BC013734.1) were 
used: 5`- TTCCTACCACCAGCAACCCTGCCA -3` (probe), 5`- 
GAATCATTCACCAGGCAAATT -3` (forward), and 5`- TTTCTGTACTGCGGGTGGAAC -3` 
(reverse). For ALOX detection the following primers and probe (Acc.No. NM_000698.1) were 
used: 5`- CTTCGAGCGTGGCGCGGTG -3` (probe), 5`- TGGACAAGCCCTTCTACAACG -3` 
(forward), and 5`- CTCGTCCACAGTCACGTCGT -3` (reverse). 
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A relative standard curve was generated by serial dilutions of cDNA. Fragments of cDNA 
corresponding to IL-6, COX-2, or ALOX that covered the TaqMan primer/probe area were 
obtained by PCR amplification. To standardize the amount of sample cDNA added to the 
reaction the calculated amount of the gene of interest was divided by the calculated amount of 
the constitutively expressed ribosomal 18S gene in the sample. These normalized amounts 
were then used to compare the relative amount of target in different samples. The expression 
level of the endogenous control gene 18S did not alter under any of the different treatments. 
 
 
 
 
 
Figure 6.9: Effect of different concentrations of GTE or EGCG on basal IL-6 mRNA expression in Caco-2 cells after 
24 h incubation. Transcriptional expression was determined by quantitative real-time PCR. Each data value is 
expressed as a percentage of the control. Data were not pooled and represent the results of 3 independent 
experiments (a-c). 
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Figure 6.10: Effect of different concentrations of GTE or EGCG on IL-1β-influenced IL-6 mRNA expression in Caco-
2 cells after 24 h incubation. Transcriptional expression was determined by quantitative real-time PCR. Each data 
value is expressed as a percentage of the control. Data were not pooled and represent the results of 3 independent 
experiments (a-c). 
 
 
 
Figure 6.11: Effect of different concentrations of GTE or EGCG on (a) basal or (b) IL-1β-influenced COX-2 mRNA 
expression in Caco-2 cells after 24 h incubation. Transcriptional expression was determined by quantitative real-
time PCR. Each data value is expressed as a percentage of the control. Data represent the results of one single 
experiment. 
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 Figure 6.12: Effect of different concentrations of GTE or EGCG on (a) basal or (b) IL-1β-modulated ALOX mRNA 
expression in Caco-2 cells after 24 h incubation. Transcriptional expression was determined by quantitative real-
time PCR. Each data value is expressed as a percentage of the control. Data represent the results of one single 
experiment. 
 
 
6.3.3 Results and discussion 
The data in figures 6.9 to 6.12 represent the results of single independent experiments. The 
results of the effect of GTE or EGCG on basal IL-6 mRNA expression in Caco-2 cells were 
inconclusive (Figure 6.9a-c). In two of three experiments IL-1β or 0.4 mg/ml GTE induced IL-6 
mRNA expression 1.5- to 4-fold. In the literature IL-1β has been described as an inductor of IL-
6 mRNA expression in Caco-2 cells (Parikh et al., 1997). The effect of GTE or EGCG on the 
IL-1β-influenced IL-6 mRNA expression found in these two experiments were also inconclusive 
(Figure 6.10a-c). However, at a concentration of 0.01 mg/ml GTE enhanced the effect of IL-1β-
mediated IL-6 mRNA expression. In Caco-2 cells, the mRNA expression of COX-2 was not 
induced above 2-fold by GTE, EGCG, or IL-1β (Figure 6.11a). This was in contrast to results 
described in the literature (Porath et al., 2005).  Also the effect of GTE or EGCG on IL-1β-
influenced COX-2 mRNA expression could not be determined in Caco-2 cells (Figure 6.11b). 
Furthermore, also the effect of GTE, EGCG, or IL-1β on ALOX mRNA expression could not be 
clarified in Caco-2 cells (Figure 6.12). A slight induction of ALOX mRNA expression was 
observed for GTE or EGCG. Because of these discouraging results the experiments 
concerning the influence of GTE on COX-2 and ALOX mRNA expression were not repeated. 
Taken together, due to the inconsistent results, the effect of GTE on IL-6 mRNA expression in 
the colon carcinoma cell line Caco-2 remains controversial and might be clarified using a 
different intestinal cell line. 
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8. Conclusions and outlook 
 
Pharmacokinetic herb-drug interactions often occur as a result of activity changes of drug-
metabolising and transporting proteins and have received much attention recently (Butterweck 
et al., 2004). These proteins seem to participate in the pathology as well as in therapy 
resistance of several diseases including cancer and IBD (Van Tellingen, 2001; Farell et al., 
2000). Because of the recent increase of green tea consumption due to its potential health 
promoting effects there is a need for clarification of possible drug-interactions of green tea. 
 
In this thesis the effect of a commercially available GTE on the expression and function of 
several intestinal transporters and drug-metabolising enzymes was investigated. We have 
shown that GTE, at low concentrations, does not alter P-gp or MRP2 mRNA expression in LS-
180 cells. The functional activity of MRP2 was inhibited by GTE at a concentration found to 
exert toxic effects in intestinal cell lines. GTE did not induce CYP3A4 expression in LS-180 
cells, but did dose-dependently inhibit CYP3A4 metabolic activity in vitro. Although CYP3A4 
and P-gp have strikingly overlapping substrates and inhibitors, the ability to predict the 
potential of GTE-mediated P-gp functional inhibition is hindered by the complexity of the 
enzyme kinetics. Thus, despite literature data suggest a functional inhibitory activity of GTE 
against P-gp, it remains to be elucidated whether GTE inhibits P-gp function. However, GTE 
did dose-dependently induce CYP1A, although with cell line specific differences between the 
expression of the isoenzymes CYP1A1 and CYP1A2. The functional activity of CYP1A2 was 
inhibited by GTE, which is in accordance to its reported chemopreventive character. 
 
These results may contribute to the prediction of possible effects of GTE on therapeutical 
effectiveness. Regarding the inhibitory activity on CYP3A4 function, GTE may represent a 
potential candidate for therapeutic use. Co-administration of GTE with chemotherapeutic or 
antiviral drugs may increase their cellular concentration, which may enhance the therapeutic 
effect. On the other hand, a dose-reduction with the desirable side effects of lower toxicity and 
a prolonged therapeutic window might become possible. Nevertheless, a general increase of a 
potential toxicity of drugs metabolised by CYP3A4 due to co-ingestion of green tea has to be 
considered. However, clinical studies in humans have to be performed to overcome the 
preliminary character of cell culture based observations. 
 
The intestinal mucosa as a site of immune regulation has come into focus due to observed 
high titers of inflammatory mediators in diseases with chronic intestinal inflammation including 
IBD (Neutra et al., 2001; Sartor, 1994). Thus, the identification of herbal preparations inhibiting 
the activity or the production of these mediators is highly desirable for therapeutical 
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application. Green tea has been shown to represent such a potential candidate (Sueoka et al., 
2001). 
 
In this thesis we assessed the ability of GTE to interfere with the gut mucosal production of the 
chemokine IL-8, which is involved in neutrophil migration and activation. We found that GTE 
specifically inhibits IL-8 secretion of Caco-2 cells, while inducing its expression. GTE did not 
alter IL-1β mRNA expression in these cells, but slightly induced TNF-α production in theses 
cells. As IL-8 is a pivotal regulator of neutrophil recruitment and respiratory burst, this result 
may have implications for preventive or attenuating therapies for the treatment of IBD. 
Therefore, data on the effect of GTE on IL-8 in biopsies of IBD patients should be generated in 
a future step. Furthermore, the reported anticancer and chemopreventive potential of green 
tea might be, at least in part, based on the effects observed. This is supported by the use of 
the cancer cell line Caco-2 in our experiments. 
However, as the effects of IL-8 are dependent on the binding to its receptors, a possible 
influence of GTE on the expression and function of these have to be elucidated in neutrophils. 
Because of the high redundancy of different chemokines and cytokines, possible effects of 
GTE on further inflammatory mediators need to be clarified. Due to the complex interplay of 
pro- and anti-inflammatory stimuli in vivo, the effect of GTE on the intestinal inflammatory 
process should be investigated in suitable animal models. Nevertheless, GTE has been shown 
to exhibit antiinflammatory activity in intestinal cells in vitro, which are likely to occur in vivo as 
higher concentrations of GTE after oral administration can be obtained in the intestine in 
comparison to other tissues. 
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